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CHAPTER I. GENERAL INTRODUCTION 
Enzymes are catalysts of biological reactions, and are characterized by their substrate 
specificity, specificity of reaction and ability to be regulated. The purpose behind enzymatic 
studies is to determine what chemical reaction is catalyzed, and how the structural features of 
an enzyme are responsible for a particular fimction. The aspects of enzymes studied are the 
catalytic mechanism of the enzyme, the association states of the enzyme, the constituents of 
substrate specificity and the regulation of the enzyme. Studies such as these are called 
structure-function studies. 
By changing specific interactions and determining how this changes the action of the 
enzyme, we can determine what specific interactions are responsible for specific functions. 
This can yield the mechanisms for inactivation of the enzyme, as well as the design of more 
potent agonists, antagonists and inhibitors. This knowledge can be extrapolated to define 
actions of enzymes whose function may be known but have not been completely 
characterized or crystallized. This information could also be used to help predict the action of 
proteins which are postulated fix)m genes in the various gene databases resulting from the 
genome sequencing projects, for example the Saccharomyces cervesiae, Drosophia 
melanogaster and Helicobacter pylori genomes. 
One enzyme studied as a model system in our laboratory is adenylosuccinate 
synthetase (E.C. 6.3.4.4, L-aspartate;IMP ligase, GDP forming; AMPSase). This enzyme is 
the first committed step in the formation of adenine monophosphate (AMP) firom the branch 
point of inosine monophosphate (IMP) in de novo purine nucleotide biosynthesis. The pool 
of adenine nucleotides is of vital importance for both cellular replication and cellular energy 
stores. Due to this importance, AMPSase is essential for cellular growth. Indeed, there has 
been no organism yet found that does not have an isozyme of AMPSase. It has also been 
found to have changes in disease states, such as acute lymphomatic leukemia (1), to be a 
target of natural antibiotics (2) and a proherbicide (3). 
The role of specific interactions at the interface of the enzyme dimer, and the roles of 
specific interactions between the enzyme and substrates in the active site of the enzyme are 
the focus of this dissertation. Interactions were studied by producing site-directed mutants of 
AMPSase as guided by comparison of the unligated and ligated crystal structures. The wild-
type and mutant AMPSases were then characterized by biochemical and biophysical 
approaches. These included determination of their kinetic parameters utilizing 
spectrophotometric assays, and study of their global conformations by circular dichroism 
(CD), analytical ultracentrifugation, and matrix-assisted laser desorption ionization (MALDI) 
studies. 
Thesis Organization 
This thesis is a general introduction and review of the relevant literature, followed by 
a series of manuscripts, and a general conclusion. Studies on the interactions of specific 
residues at the interface of the AMPSase dimer, and the implications the dimeric form of the 
enzyme has on the action and regulation of the en^me are the focus of Chapter 11. Chapter 
ni examines the interactions between a group of side-chain residues and the S'-phosphoryl 
group of IMP in the active site near one dynamic loop of the enzyme. The expected and 
unexpected results to binding of IMP and catalytic activity of the en^one are discussed. A 
group of P-branched side-chains is focus of Chapter IV, which discusses their role in the 
detennination of substrate binding of IMP and L-aspartate. The role of Vai^^^ in determining 
the specificity of the L-aspartate binding site, though there are no direct interactions between 
it and L-aspartate found in the crystal structure of the enzyme, is examined. 
Literature Review 
In 19SS, inosine monophosphate (IMP) was first recognized as a precursor of adenine 
monophosphate (AMP) in rabbit bone marrow extracts by Abrahams and Bently (4) and also 
by Carter and Cohen from yeast extracts (5). Carter and Cohen also recognized an 
intermediate product is involved in this pathway, and were able to purify and identify this 
intermediate as adenylosuccinate (adenylosuccinic acid, AMPS) (6). Soon afterwards, 
Lieberman showed that adenylosuccinate could be formed from IMP in Escherichia coli (£ 
coll) extracts. Additionally, he determined the nitrogen source of the reaction was L-
aspartate (ASP), not ammonia as found in the de novo biosynthetic pathway for pyrimidines, 
and the energy source of the reaction was guanine triphosphate (GTP) (7). The overall 
reaction described is: 
Mg^* 
L-aspartate + IMP + GTP < • adenylosuccinate + GDP + Pi (Reaction 1) 
The enzyme which catalyzes this reaction is adenylosuccinate synthetase [E.C. 
6.3.4.4, IMP:L-aspartate ligase, GDP forming, AMPSase]. Adenylosuccinate is formed from 
the addition of aspartate to the C6 position on the purine ring of IMP, with the hydrolysis of 
the Y-phosphate of GTP. In the final step of de novo pathway of AMP synthesis fn>m IMP, 
adenylosuccinate is cleaved by the enzyme adenylosuccinate lyase, forming AMP and 
fumerate. Adenylosuccinate synthetase is an essential enzyme when no extraneous source of 
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adenine is present; i.e. when AMP cannot be formed through salvage pathways. With the 
exception of human erythrocytes, it has been found in all organisms and tissues studied (8). 
Numerous studies have been undertaken to understand the kinetic and catalytic mechanisms 
of the reaction, structure of the enzyme and roles specific residues play in substrate binding 
and catalysis. 
Kinetically, the reaction mechanism is sequential rapid-equilibrium random ter-ter 
(9), though one isotope exchange study has suggested nucleotide binding before L-aspartate 
binds the enzyme is slightly preferred (10). From 1956 to 1977, three different mechanisms 
were proposed for the catalysis of Reaction 1 by AMPSase, all of which are consistent with 
the random ter-ter model. Of these, the most widely accepted mechanism involves the attack 
of the 6-oxo position of IMP by the y-phosphoryl group of GTP, forming the intermediate 6-
phosphoryl IMP. This is followed by the nucleophillic attack of the 6-phosphoryl IMP by the 
amino nitrogen of aspartate, resulting in adenylosuccinate, GDP and Pi, as was proposed 
separately by Lieberman and Fromm (7,11). 
The two other mechanisms are a concerted mechanism proposed by Miller and 
Buchanan, where all three substrates interact simultaneously (12), or IMP-aspartate reaction 
followed by GTP hydrolysis as proposed by Markham and Reed (13). Support for the 
exchange of the y-phosphoryl of GTP to IMP before reaction with aspartate comes from 
positional isotope exchange studies utilizing [y-''0] GTP. Isotope exchange occurred only 
when IMP is present (10). Crystal structures with the presence of 6-thiophosphoryi IMP (14) 
and 6-phosphoryl-IMP (IS) in the active site are additional support. However, no studies 
performed to date can definitively exclude the remaining two mechanisms. 
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Early studies used muscle adenylosuccinate synthetase purified mainly from skeletal 
muscle tissue, as muscle contains a relatively large quantity of the enzyme. In 1977, 
Matsuda identified a second isozyme of adenylosuccinate synthetase from rat liver tissue 
(16). The two isozymes have been termed the muscle (M), or basic, isozyme with a pi of 8.9, 
and non-muscle (L), or acidic, isozyme with a pi of 5.9. The non-muscle isozyme was fu^ 
identified from liver, thus the L designation (16). The two isozymes have been distinguished 
upon the basis of their tissue specificity, muscle tissue expressing the basic (M) enzyme 
exclusively, while other tissues have varying ratios of both isozymes. Besides their tissue 
localization, the isozymes also differ in their physical parameters, namely their isoelectric 
points, kinetic parameters, purification and intracellular interactions. 
The muscle and non-muscle adenylosuccinate synthetase genes were cloned in 1991 
and 1994, and are respectively named AdSSl and AdSS2 (17,18). Comparison of the 
deduced amino acid sequences shows 89% similarity and 78% identity between the muscle 
and non-muscle sequences, performed by BESTFIT (GCG analysis program) (17). Between 
either AdSSl or AdSS2 and AMPSase, there is 54% similarity and 43% identity. The non-
muscle isozyme, AdSS2, and the E. coli enzyme are similar in their pi, purification, and 
kinetic parameters of the enzyme, so AdSS2 is thought to be biosynthetic in nature, 
producing the adenine nucleotides necessary for cellular fimction. The results of a 
regeneration study support this biosynthetic role for AdSS2. Ikegami and Matsuda reported 
that after injury to liver tissue, which contains both AdSSl and AdSS2, the non-muscle to 
muscle isozyme ratio changes from 60:40 before injury to 80:20 during regeneration (19,20). 
A second role exists for adenylosuccinate synthetase in muscle cells, as part of the 
purine nucleotide cycle (PNC). The cycle is composed of the en^rmes adenylosuccinate 
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synthetase, adenylosuccinate lyase and AMP deaminase as first proposed by Loweinstein in 
1972 (21). The cycle involves the reaction of IMP to AMP, through the enzymes AMPSase 
and adenylosuccinate lyase, then recycling the AMP back to IMP by the enzyme AMP 
deaminase (Figure 1). The net result of this cycle is the production of fumarate (from the 
adenylosuccinate lyase reaction) and ammonia (from the AMP deaminase reaction), at the 
expense of one GTP. The overall net reaction being: 
L-aspartate + OTP+H2O —> fumarate + GDP+P, + NH3 (Reaction 2) 
The purpose of the cycle has been proposed to be a means of keeping a high ATP/AMP ratio 
in the cell during periods of exercise, a method of removing ammonia from the intracellular 















Figure 1. The Purine Nucleotide Cycle, en^mes shown in italics, (after (21)). 
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The purine nucleotide cycle has been extensively reviewed, and further detail on the cycle 
can be found elsewhere (21,22). The importance of the PNC in active muscle tissue has been 
shown through several studies of exercise intolerant patients (patients who experience 
pronounced fatigue after short periods of energetic activity). In these individuals, AMP 
deaminase is deficient, and there is a buildup of intracellular concentrations of AMP (23). 
As the PNC has been proposed to play an active role in muscle cell metabolism, the 
muscle isozyme has been associated with the PNC and the non-muscle isozyme has not. 
While the non-muscle isozyme produces the adenine nucleotides necessary for cellular 
function, it is thought that the muscle cell produces sufficient AMP for cellular function as 
the side product of the PNC. These distinctions are due to both the localization and kinetic 
parameters of the isozymes. Consistent with this hypothesis, the muscle isozyme has been 
found to have an elevated Km'^ and slightly decreased and Km as compared to the 
acidic isozyme or AMPSase (8). Additionally, high concentrations of IMP have been 
reported to inhibit the muscle isozyme (8). 
As well as kinetic differences between the muscle and non-muscle isozymes, 
evidence exists for other intracellular differences. The muscle iso^rme specifically 
associates with F-actin, and other actin complexes, while no association is found for the non-
muscle isozyme (24-26). The stoichometric ratio of muscle isozyme to F-actin binding is 1 
mol of the muscle isozyme to 4 mol of F-actin, with a dissociation constant (KD) for binding 
of 0.72 ^M. The interaction with F-actin is unique to the basic isozyme, as rat acidic 
isozyme was not found to associate with F-actin (25). The specificity and level of association 
between the basic isozyme and actin implies that there is some physiological significance to 
this interaction, however this is yet to be determined. 
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The fact that there is an interaction of adenylosuccinate synthetase with other 
intracellular molecules, such as F-actin, is not unique to the muscle isozyme. Sacchromyces 
cervesiae {S. cervesiae) adenylosuccinate synthetase has been found to interact specifically 
with the T-rich autonomously replicating sequence in the yeast genome (26). A modeled 
structure for the S. cervesiae enzyme suggests the interaction is through a cluster of basic 
residues on the surface that are not found in other adenylosuccinate synthetases (27). In a 
recent study, it was suggested that the S. cervesiae AMPSase interaction with the ARS 
sequence is regulated by its state of phosphorylation. While the native purified S. cervesiae 
AMPSase has DNA binding capabilities, a homologously overexpressed and purified S. 
cervesiae AMPSase does not. Additionally, when the native S. cervesiae enzyme is 
dephosphorylated its DNA binding capabilities are lost, while retaining full enzymatic 
activity (28). 
Overexpression of E. coli adenylosuccinate synthetase was first achieved in 1987, by 
Bass et. al. (29), and the entire sequence for the E. coli adenylosuccinate synthetase gene, 
purA, was first published in 1988, by Wolfe and Smith (30). Since then, sequences for 35 
AMPSase genes from unique sources have been described, with identities ranging from 84% 
to 29% identical to the E. coli protein sequence by BLASTP search of the non-redundant 
Swissprot sequences (31). The first crystallization of any form of adenylosuccinate 
synthetase was reported in 1977 by Ogawa of the rabbit muscle enzyme (32), however the 
crystal structure of the enzyme was not solved until 1993 by Poland et. aL (33), of the £1 coli 
enzyme, with a refined structure of the unligated £. coli synthetase reported in 1995 (34). 
Since then, the structure of the enzyme fix)m E. coli complexed with varying ligands and 
inhibitors has been solved (14,15,35-38). Additionally, the structure has been solved for the 
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synthetase from three other sources - Pyrococcus species (39), Arabidopsis thaliana and 
Triticum aestivum (40). The overall three-dimensional structure remains very consistent 
from all sources, though the Pyrococcus species shows some variation, due to its 
thermophillic source. 
The crystallized enzyme is a homodimer with head-to-tail synunetry from all reported 
sources (35,39,40). Between the unligated and ligated crystal structures there are no global 
changes, however there are three disordered loops which become ordered upon ligand 
binding. These loops are known as the 40's loop, the 120's loop and the 300's loop (35,37). 
Other minor conformational changes occur in the ligated structures, all are minor movements 
which collapse the structure inwards towards the enzyme active site (35). 
Examination of the crystal structures ligated with various ligands can indicate which 
resides which are potentially important in interactions between the substrates and the 
enzyme. Resides which are important or essential for catalysis can also be suggested. Using 
the information gained from the crystal structures, a number of site-directed mutants have 
been made and characterized. These mutants have been utilized to investigate the substrate-
enzyme interactions, mechanistic implications, enzyme-enzyme interface interactions and 
conformational changes occurring upon substrate binding. 
While IMP, GTP and their inhibitors have been crystallized in the active site of the 
enzyme, only inhibitors of L-aspartate have been successfully crystallized. Thus, good 
indications of major interactions important for IMP and GTP recognition by the enzyme 
exist. For example, the guanine binding site was determined to consist of conserved guanine 
binding residues (N/T/Q)KXD (residues 330-333), and the phosphate binding loop (*P-loop') 
of GXXXXGK (residues 12-19X41). Asp^^^ was determined to be an ultimate determinate 
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for recognition of the guanine base of GTP by the enzyme, for upon mutation of this residue 
to an asparagine, specificity of the enzyme was changed from GTP to xanthine triphosphate 
(XTP). Indeed, the mutant was determined to be more catalytically efficient utilizing XTP 
than the wild-type enzyme was with GTP (42). The importance of an aspartate in the GTP 
base recognition has been seen in other GTP binding enzymes, for example the elongation 
factor EfTu (43). The phosphate-binding loop was shown to contain the catalytic acid Asp'^, 
which when mutated to alanine yields a catalytically dead enzyme (44). 
One characteristic of the G-protein superfamily is the 'P-loop' involved in binding the 
phosphates of the GTP (45). Containing the conserved 'P-loop', AMPSase is peripherally a 
member of the G-protein superfamily. For the members of the superfamily, GTP binding is a 
'on/off switch, where the unbound or GTP bound state of the protein is 'on', and hydrolysis 
to GDP turns the protein 'off (45). Thus, GTP binding and subsequent hydrolysis to GDP is 
involved in the transduction of a signal within a cell for these proteins. In these proteins, the 
preference is to maintain the GTP bound state, and hydrolysis by the enzyme is slow. 
AMPSase is only peripherally a member of this superfamily as it utilizes the binding and 
hydrolysis of GTP to catalyze a reaction, instead of as an 'on/ofiT signal. 
Two residues in the IMP binding site, Glu^^ and Glu^^, yielded unique mechanistic 
implications. The side-chains of GIu^^ and Glu^ are located in the vicinity of C6 of IMP, 
and thus postulated to be important in catalysis or substrate binding. Mutation of these 
residues to methinonine (Glu^^) or glutamine (GIu^^ and Glu^^) has large effects on the 
catalysis of the enzyme (decreases kcu 4- to 60-fold), but only minor effects on the kinetic 
parameters. The kinetic studies show that Gln^^ works in concert with the catalytic acid. 
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Asp'^, to stabilize the 6-oxyanion form of IMP, allowing for nucleophillic attack on the y-
phosphate of GTP (46). 
Determination of the critical interactions between the enzyme and the substrate L-
aspartate are less well defined, as only hadacidin, an inhibitor competitive to L-aspartate, has 
been crystallized. The enzyme has shown the strictest specificity for substrates at this site, 
the only known substitute being hydroxylamine (8). The only previously identified residues 
important for aspartate recognition and binding consist of a group of conserved arginine 
residues (47). Mutation of Arg^®^, Arg^®^ and Arg^°^, individually, to Leu raised the 
50- to 200-fold, compared to wild-type AMPSase, while causing only minor decreases in km-
Indeed, arginine residues have been found interacting with the a- and P- carboxyl groups of 
aspartate in most aspartate binding proteins, for both enzymes and receptors (48-50). 
Kang determined there are two Mg^^ ions required for activity in AMPSase. The first 
Mg^^ is associated with the fi- and y- phosphoryl groups of GTP, and Asp'^ fix)m the enzyme 
as seen in the crystal structure (37). The second Mg^"^ Kang postulated to be coordinated in 
association with the a- and p- carboxyl groups and amino group of L-aspartate. The purpose 
of this association is to activate the protonated amino group, generating a better nucieophile 
for attack of the 6-phosphoryl IMP intermediate (SI). Further support for the interaction of 
the a- and |)-carboxyl group of aspartate with Mg^"*" is that the alternative substrate 
hydroxylamine has a Hill coefficient of 1 (47). As of yet, a second Mg^*^ ion has not been 
found in any crystal structure. 
The first indication that the dimeric form of the enzyme is the active form are from a 
sub-unit complementation study, where two inactive mutants (Asp'^-^Ala and Arg'^^->Leu) 
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were combined and allowed to form a heterodimer. The heterodimer yields a single, 
competent active site per dimer (S2). However, the complementation study cannot rule out 
the possibility of an active monomer for the wild-type enzyme. 
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CHAPTER II: A STUDY OF Escherichia coli ADENYLOSUCCINATE 
SYNTHETASE ASSOCIATION STATES AND THE INTERFACE 
RESIDUES OF THE HOMODIMER* 
A paper published in the Journal of Biological Chemistry^ 
Wenyan Wang^, Andrea Gorrell^ Richard B, Honzatko^ and Herbert J. Fronun^"* 
ABSTRACT 
The state of aggregation of adenylosuccninate synthetase &om Escherichia coli is a 
point of controversy, with crystal structures indicating a dimer and some solution studies 
indicating a monomer. Crystal structures implicate Arg'^ ^ and Asp '^ in stabilizing the 
dimer, with Arg'^ ^ interacting directly with bound IMP of the twofold related subunit. 
Residue Arg'^ ^was changed to Lys and Leu, and residue Asp '^ was changed to Ala. MALDI 
spectroscopy and analytical ultracentrifligation of the wild-type and the mutant enzymes 
indicate a mixture of monomers and dimers, with a majority of the enzyme in the monomeric 
state. In the presence of active site ligands, the wild-type enzyme exists almost exclusively as 
' This research was supported in part by Research Grant NS10S46 from the National Institutes of Health, by the 
United States Public H^th Services, and by Grants MCB-92I8763 and MCB-9316244 frvm the National 
Science Foundation. This is Journal paper J-I6827 of the Iowa Agriculture and Home Economics Experiment 
Station, Ames (Project 3191). 
^ Reprinted with permission from The louinal of Biological Chemistry (1997) 272,7078-7084. Copyright 
*1997 by The American Society for Biochemistry and Molecular Biology, Inc. 
^ Graduate students and profi»sors, respectively. Gorreli performed mutagenesis, kinetic characterizaion and 
analytical ultracentrifligation of Arg'*'-*Lys. 
* To whom all correspondance should be addressed: Dr. H. J. Fromm, Department of Biochemistiy and 
Biophysics, Iowa State University, Ames lA SOOI1 Phone; (515)294^971 Fax: (515)294^)453 email: 
hjfromm@iastate.edu 
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a dimer while the mutant enzymes show only slightly decreased dissociation constants for the 
dimerization. Initial rate kinetic studies of the wild-type and mutant enzymes show similar 
kcai and Kq, values for aspartate. However, increases in the values of GTP and IMP are 
observed for the mutant Changes in dissociation constants for IMP are comparable to 
changes in values. Our results suggest that IMP binding induces enzyme dimerization, 
and that two residues in the interface region, and Asp"', play significant roles in IMP 
and GTP binding. 
INTRODUCTION 
Adenylosuccinate synthetase (AMPSase)' [IMP:L-aspartate ligase (GDP forming), 
EC 6.3.4.4.] catalyzes the first committed step in the conversion of IMP to AMP in the de 
novo synthetic pathway for purine nucleotides; 
^ Mg^" 
IMP + L-aspartate + GTP ' ^ adenylosuccinate + GDPPi 
Adenylosuccinate is then cleaved by adenylosuccinate lyase to form AMP and fumarate. 
AMPSase also plays a role in the salvage and nucleotide interconversion pathways (1). The 
enzyme is potentially a target of a natural herbicide (2) and of a drug used in the treatment of 
pediatric leukemia (3). Better understanding of the synthetase could support efforts in the 
design of drugs against HIV and cancer (4). 
Three different mechanisms have been proposed for the catalytic action of AMPSase 
(1). The most widely accepted mechanism involves a 6-phosphoryI-IMP intermediate formed 
' The abbreviations used are: AMPSase, adenylosuccinate synthetase; MALDI matrix-assisted laser desorption 
ionizalion. 
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by the nucleophilic attack of the 6-oxo group of IMP on the y-phosphorus atom of GTP (5,6). 
A second nucleophilic attack by the amino group of aspartate on C6 of 6-phosphoryl IMP 
displaces the phosphate and forms adenylosuccinate. 
AMPSase was first purified to homogeneity in 1976 from Escherichia coli (7) and has 
since been purified and characterized &om many sources (1). The pvrA gene, which in E. 
coli codes for AMPSase, was cloned in 1986 (8) and used in the construction of an 
overexpression system (9). The crystal structure of AMPSase was determined to 2.8 A (10) 
and later refined to 2.SA and 2.0 A (11). bi crystal structures, the enzyme exists as a 
homodimer. Two nearly independent regions contribute to the interface between the 
polypeptide chains of the synthetase dimer. Residues putatively involved in the binding of 
IMP lie at or near the interface between polypeptide chains in the dimeric form of the 
enzyme. One of the residues. Asp"', may play an important role in holding the subunits in 
close contact by hydrogen bonding to Arg'^ ^ and Lys'^ ° of the 2-fold related subunit. Indeed, 
when Lys'^ " and Arg'^ ^ were replaced by isoleucine and leucine, respectively, and 
showed significant increases (12,13). 
Crystal structures imply that Arg'^ ^ is involved in IMP binding to the active site of the 
symmetry-related subunit of the dimer. Arg'^ ^ may also stabilize the interface through at 
least one hydrogen bond. Slow phase inactivation of AMPSase was observed when 
guanosine-5'-0-[S-(4-bromo-2,3-dioxobutyl)] thiophosphate modifies the enzyme at Argl43. 
Modification of Argl43 is prevented by adenylosuccinate alone or by a mixture of GTP, 
MgClzandlMPCH). 
The cited findings suggest a direct relationship between dimer formation and 
AMPSase activity. AMPSase exists as a monomer in solution (15), yet the en^me is a dimer 
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in crystal structures (10,11). The discrepancy between the level of aggregation of the enzyme 
in solution and the crystal is the basis of an important question: Does AMPSase function as a 
monomer or as a dimer? MALDI mass spectroscopy, analytical ultracentrifiigation, and 
initial rate kinetics were used to determine the state of aggregation and activity of wild-type 
AMPSase and several interface mutants. Arg'^ ^ was replaced with leucine to remove the 
guanidinium group and yet retain some of the hydrophobic attributes of the original side 
chain. Mutation of Arg'^ ^ to lysine retains the positive charge, but limits hydrogen bonding 
opportunities of the side chain at position 143. Asp '^ was replaced with alanine so as to 
disrupt the Lys'^ °-Asp"* salt link observed in the crystalline dimer. Our findings indicate 
that the £. coli enzyme dimerizes in response to active site ligands and that, on the basis of 
sequence homology, dimerization may be a property common to all known adenylosuccinate 
synthetases, regardless of source. 
EXPERIMENTAL PROCEDURES 
Materials—GTP. IMP, L-aspartate, phenyhnethylsulfonyl fluoride, and bovine serum 
albumin were obtained from Sigma. A site-directed mutagenesis kit was obtained from 
Amersham. Restriction enzymes were obtained from Promega. £. coli strain XL-1 blue 
was obtained from Stratagene. E. coli strainpurA' H1238 was a gift from Dr. D. Bachman 
(Genetic Center, Yale University). Other reagents and chemicals used in the experiments 
were obtained from Sigma if not specified. 
Site-directed mutagenesis—^Recombinant DNA manipulation was performed by using 
standard procedures (16). The plasmid containing a 1.8-kb BamHI - Hindm fragment from 
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PMS204 ligated into PUCl 18 was used in the mutagenesis step. All mutagenic 
oligonucleotide primers used in the experiments were synthesized on a Bioresearch 8S70EX 
automated DNA synthesizer at the DNA Facility at Iowa State University. Mutagenesis was 
performed according to the protocol provided by Amersham. The mutations were confirmed 
by DNA sequencing using the chain termination method (17) at the Iowa State University 
DNA Facility. The 1.8-kb Bam HI - HindOl fragment with the desired mutation was ligated 
back into PMS204 and transformed into XL-1 blue cells. The plasmids isolated from that 
strain were used to transform E. coli strain purA' H1238, the strain from which AMPSase 
was purified. 
Protein assay—Protein concentration was determined by the Bradford (18) method 
using bovine serum albumin as the standard. Concentrations reported here refer to 
monomers. 
Purification of wild-tvpe and mutant adenvlosuccinale synthetase—^The wild-type and 
mutant enzymes were purified as described elsewhere (9). The purity of the enzyme was 
checked by SDS-PAGE according to Laemmli (19). AMPSase activity was determined as 
described earlier (20). 
Kinetic studies of wild-type and mutant AMPSase—The concentrations of stock 
solutions of nucleotides were based on their molar extinction coefficients at 253 nm for GTP 
and 248 nm for IMP. For each enzyme assay, the increase at 290 nm was recorded at 25aC. 
The enzyme assay solution contained 20 mM Hepes (pH 7.7) and 5 mM MgCl2. When GTP 
was the variable substrate, the concentration of aspartate was fixed at 5 mM, and the IMP 
concentration was fixed at 450 ^M for wild-type AMPSase and at 12 mM for the mutants. 
When IMP was the variable substrate, the concentration of GTP was fixed at 300 ^M, and 
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aspartate was fixed at S mM. When aspartate was the variable substrate, the concentration of 
GTP was fixed at 300 ^M, and the concentration of IMP at 450 |iM for the wild-type 
AMPSase and 12 mM for the mutants. 
To obtain the values of Kj. and Kjb, dissociation constants for IMP and GTP, 
respectively, a 5X5 matrix of substrates were used with each enzyme. The enzyme assay 
solution contained 20 mM HEPES (pH 7.7), 5 mM MgCl2, and 5 mM Aspartate, and varying 
GTP and IMP concentrations. The kinetic data were fit to equation 1 using a program written 
in Minitab in place of the Omnitab program described by Siano et al. (21); 
-=— l+-«-+—(Eq.l) 
V A B AB \ ' 
It was assumed that the kinetic mechanism for the mutant enzymes was the same as the rapid-
equilibrium Random mechanism described for the wild-type enzyme (5,6) and thus KiaKb= 
K.Kib. 
In Equation 1, v is the initial rate, V,„ is the maximal velocity, A is the GTP concentration, B 
is the IMP concentration, K, is the Michealis constant for GTP, Kb is the Michealis constant 
for IMP, and Kj, is the dissociation constant for IMP. Kjb is the dissociation constant for 
GTP. 
Circular Dichroisim Spectrometry—Circular dichroisim spectra for the wild-type and 
mutant enzymes were acquired on a JASCO J700 spectropolarimeter equipped with a data 
processor. Samples, 100 |ig/ml of enzyme, dialyzed against 5 mM KPi (pH 7.0), 1 mM 
EDTA, 1 mM p-mercaptoethanol, were placed in a 1 cm cuvette, and data points were 
collected in 0.1 nm increments. Each spectrum was corrected for background contributions 
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of the buffer and smoothed using the spectropolarimeter program. The data were analyzed by 
JASCO analysis software or by PSIPLOT. 
MALDI mass spectrosconv—^All of the enzymes were dialyzed against 5 mM KPi 
buffer (pH 7.0), I mM EDTA, and I mM P-mercaptoethanol. Protein concentration was 
adjusted to I mg/ml. Samples of 0.5-1.0 |il were loaded with 0.5 |il of freshly made 3,5-
dimethoxy-4-hydroxy-cinnamic acid matrix. Bovine serum albumin was used as the internal 
calibration standard. Data were collected on a Finnigan LASERMAT 2000 MALDI-TOF 
mass analyzer in the Protein Facility of Iowa State University and were analyzed by the 
LASERMAT 2000 data processing software. 
Analytical ultracentrifu^ation (sedimentation eauilibrium) of wild-type and mutant 
AMPSase — Analytical ultracentrifugation experiments were performed using a Beckman 
Optima XL-A ultracentrifuge. The temperature of the rotor (AN-60 Ti) was set a 4''C. Rotor 
speeds were set at lOK, 14K, and 18K. Wild-type and mutant AMPSase samples were 
prepared in 5 mM KPi buffer (pH 7.0) at concentrations of 2.9 to II.6 ^M corresponding to 
absorbences of 0.2 - 0.8 (280 nm, 1 cm cuvette). Concentration dependent equilibrium 
sedimentation was performed with concentrations of 4.4 ^M and 58 ^M, corresponding to 
Aagonm readings of 0.3 and 4.0. Samples of AMPSase in the presence of ligands were 
prepared by dialysis overnight against 5 mM KPi (pH 7.0), 5 mM succinate, 5 mM MgClj, 20 
|iM IMP, and 20 ^M GTP. Protein samples were centrifliged at least 10 h before the 
collection of data. Stepwise radial scans were performed at 280 nm for the wild-type and 
mutant enzymes with and without ligands, and at 280 nm, 295 nm and 300 nm for the 
concentration dependent equilibrium sedimentation. Each reading is the average of 30 points, 
with nominal spacing of 0.001 cm between radial positions. Absorbence readings were 
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measured at 1 h intervals to ensure that equilibrium had been reached. Three scans were 
averaged and the data were analyzed by the method of Van Hold and Weischet (22) using the 
"IDEAL" model on the Optima XL-A Analysis Software (Version 2.0) to get the apparent 
molecular weight (MWapp). Thepartialspecific volume of AMPSase, 0.737 cmVg, was 
calculated by the method of Cohn and Edsall (23). 
Equilibrium sedimentation data for the wild-type and mutant enzymes obtained at three 
different rotor speeds were analyzed using 'SELF' model in multiple data set analysis 
program Optima XLA. The association constants (K J for the monomer-dimer equilibrium 
were obtained using the following equation: 
Cr = E + Cm^ exp [M(l- up)(i)V-fo^)/2RT] + 
(Cnuo)'K.exp[2M(l- 5p)tt>V-r.'V2RT] (Eq.2) 
Where Cr is the concentration of the protein at a given radial position, c^^ is the 
concentration of monomer at a reference position, M is the monomer molecular weight, u is 
the partial specific volume, p is the solvent density, co is the angular velocity, r is the radial 
position in centimeters from the center of rotation, ro is the distance in centimeters from the 
center of rotation to the meniscus, T is the absolute temperature, R is the gas constant, and E 
is a correction term for a non-zero baseline. The conversion of K. into the dissociation 
constant (^M) is performed as follows: 
Kd = 2/elK, = 24.2/K,(nM) (Eq.3) 
where 8 68750 M*'cm*' is the extinction coefficient for AMPSase at 280 nm and 1 = 1.2 cm 
is the path length of the centrifuge cells. 
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RESULTS 
X-ray crystallographic studies suggest that interface residues play an important role in 
maintaining the quaternary structures of AMPSase (10,11). Two very important residues in 
this context are Arg'^ ^ and Asp"'. Arg'^ ^ in one subunit is ligated to the S'-phosphoryl of 
IMP in the active site of the juxtaposed subunit (11). Asp '^ forms a salt link with Lys'^ °, a 
residue putativeiy essential for AMPSase activity as a means of stabilizing subunit-subunit 
association. Experiments involving mutation of residues Arg'^ ^ and Asp"' were undertaken 
to gain insight into the role of these interface residues. 
Comparison of the sequence 138-148 and 228-235 in E. coli AMPSase with the 
svnthetases from other sources— Arg'^ ^ and Asp"' are conserved in the nine known 
AMPSase sequences (8,24-29,31)^ (Table I), as are Arg'^ ' and Lys'"*". In crystal structures, 
the side chain of Asp"' forms a salt bridge with Lys'^ ^, and the carbonyl of Asp"' hydrogen 
bonds to Arg'^ ^ (10,11). Chemical modification or mutation of Lys'^ ° or Arg'^ ^ inactivates 
the synthetase (12,13). Arg'^ ^ from each subunit projects into the IMP binding site of the 
symmetry-related subunit of crystallographic dimers (11). 
Mutagenesis ofthe E. coli AMPSase pur A ^ ene and purification of the mutant 
enzymes—The oligonucleotide primers used in the mutagenesis experiments are shown in 
Table n together with the sequencing primers for confinning the mutants. Arg'^ ^ was 
changed to leucine and lysine. Asp"' was mutated to alanine. These mutations altered the 
charge states of residues and/or hydrogen bonding interactions observed in crystallographic 
structures while keeping the size of the side chain comparable to that of the original residue. 
All the mutants were purified by using procedures similar to those for wild-type AMPSase, 
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with some modifications. The D231A mutant bound to the phenyl sepharose CL-4B so tightly 
that it could be eluted only by water. All the enzymes exhibited greater than 95% purity on 
the basis of SDS-PAGE and a molecular mass of 48-kDa (data not shown). 
Secondary structure analysis— Circular dichroisim spectra of the mutant and wild-
type enzymes were superimposable (data not shown) firom 200 nm to 260 nm, indicating no 
global alterations in the secondary structures of the mutants relative to wild-type AMPSase. 
Kinetic analysis of AMPSase mutants—^The kinetic parameters for GTP, IMP, and 
aspartate with various forms of AMPSase are summarized in Table HI. The values for 
aspartate illustrate that the mutants differed little from that of the wild-type enzyme, 
suggesting that Arg and Asp are not involved in the binding of aspartate. In addition, the 
mutant and wild-type AMPSases had comparable kcat values; however, values for GTP 
and IMP exhibited significant increases for the mutant enzymes relative to wild-type 
AMPSase. The values for R143K, R143L, and D231A showed 2-, 10-, and 20-fold 
increases, respectively, compared with that of the wild-type enzyme. On the other hand, 
even more dramatic changes were observed for the values of IMP. Increases in of 
100-, 100-, and 60- fold for the mutants R143K, R143L and D231 A, respectively, were 
observed relative to that of wild-type AMPSase. In addition, increases in of 20- to 30-
fold were also observed for the mutant enzymes, relative to that of the wild-type enzyme. 
These findings suggest that the residues in question contribute significantly to the binding of 
both IMP and GTP, either by stabilizing the dimer through hydrogen bonding, by direct 
interaction with IMP, or by both. The similar kinetic properties of R143K and R143L 
mutants with respect to IMP binding suggest that the positive charge of lysine alone did not 
^ F. Tatum and M. A. Steckelberg, unpublished data 
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restore wild-type properties, suggesting a precise hydrogen bonding and stereochemical role 
for R143. The models for R143K and R143L are presented and discussed below (Fig. 1). 
MALDI mass spectrometry analysis of AAfPSase— AMPSase in solution is a 
monomer (1S), whereas it is a dimer in crystals (10,11). We assumed that subunit association 
might involve interface residues such as Arg'**^; therefore, experiments were undertaken to 
evaluate this possibility. The mutant enzymes and wild-type AMPSase were analyzed by 
MALDI mass spectroscopy. A typical spectrum is shown in Fig. 2. Given the estimated 
molecular mass of the monomer as 46 kDa, three ionized species were observed from 20-kDa 
to 110-kDa, corresponding to mass values of 23.4-kDa (M = 46.6-kDa, Z = 2), 46.6-kDa (M 
= 46.6-kDa, Z = 1), 92.7-kDa (2M = 92.7-kDa, Z = 1). The existence of a 92.7-kDa peak 
indicates the presence of dimers. 
Equilibrium Sedimentation of wild-type and mutant AMPSases— Subunit association 
of wild-Q'pe AMPSase was evaluated at three different concentrations (32). Considering the 
molecular mass of the monomeric and dimeric enzymes, three different centriiiigation speeds 
were utilized (10,000,14,000,18,000). The molecular mass of AMPSase does not depend on 
either the centrifugation speed or the protein concentration under the conditions tested. 
Typical equilibrium sedimentation data are shown in Fig. 3a. Fig. 3b shows the relationship 
between wild-type protein concentration and MW^. At low concentrations (A280mn= 0.1), 
the MW^jp = 45 kDa, which matches the result determined by MALDI mass spectroscopy. At 
higher concentrations (Ajgonm^ 0.6S), the MW^,p approaches 60 kDa, which is between the 
molecular mass for monomeric and dimeric AMPSase. This observation strongly indicates 
the existence of a monomer-dimer equilibrium. Dissociation constants for dimer-monomer 
equilibria of wild-type and mutant AMPSases are shown in Table IV. At micromolar 
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concentrations of em^e in the absence of ligands, the values are approximately 10 
for all the enzymes, indicating low concentrations of dimers under these conditions. In the 
presence of active site ligands the mutant enzymes exhibited small decreases in values, 
suggesting a slight increase of dimers, whereas the wild-type en^one exhibited a large 
decrease in K<i, implying that virtually all the protein is present as dimer. Active site ligands 
apparently are less effective in the stabilization of the mutant dimers. Our findings support 
the important roles played by the interface residues in forming AMPSase dimers. 
DISCUSSION 
Conflicting reports have characterized E. coli AMPSase as a monomer (IS), and a 
dimer (9) in solution. Crystal structures of AMPSase clearly show the enzyme as a dimer in 
both the unligated (10,11) and substrate-ligated states (33). AMPSase is putatively regulated 
by such feedback inhibitors as GDP, adenylosuccinate, and adenine nucleotides (1). The 
concentration of the latter class of compounds may not vary in the cell because of the 
adenylate kinase equilibrium. An alternative mode of regulation may be linked to the state of 
association of the enzyme. We therefore undertook experiments to determine the enzyme's 
state of association under different experimental conditions. 
Protein aggregation is influenced by protein concentration, ligands, pH, temperature, 
and ionic strength (34-36). Discrepancies in reported molecular masses of AMPSase &om 
different sources may stem &om the precise conditions under which mass determinations 
were made (1). We used two widely differing approaches, MALDI mass spectroscopy and 
equilibrium sedimentation, to determine molecular mass. Data from MALDI mass 
spectroscopy clearly revealed the presence of a 92-kDa species (Fig. 2), a finding fully 
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consistent with the existence of AMPSase as a dimer in solution. The MALDI technique, 
however, cannot provide a measure of the relative amounts of monomer and dimer. 
Equilibrium sedimentation was performed to determine whether a dynamic equilibrium exists 
between the monomer and dimer forms. Our results suggest that without ligands, AMPSase is 
a mixture of both monomers and dimers, with the equilibrium greatly favoring the monomer -
70% monomer and 30% dimer at 11.4 wild-type enzyme, and the equilibrium shifts to 
favor the dimer at higher concentrations - 91% dimer and 9% monomer at S8.2 fiM wild-type 
enzyme. These observations are in harmony with X-ray difiraction studies in which only 
dimers were observed (10,11, 33). 
We failed to observe two distinct species in centrifligation experiments, suggesting 
that a rapid equilibrium exists relative to the sedimentation rate between the monomers and 
dimers in the absence of ligands. Only dimers were detected, however, when substrates were 
added to the wild-type enzyme. Ligands clearly shift the equilibrium toward the dimer and 
the kinetic barrier in dimer formation and dissociation is relatively low. On the other hand, 
mutant enzymes in the presence of ligands exhibited only slightly lower IQ values than in the 
absence of ligands, indicating a much weaker ligand-induced dimerization of mutant enzymes 
relative to the wild-type enzyme. Considering that Arg'^ ^ and Asp '^ are well conserved in all 
the AMPSase sequences, the resiilts here also suggest that AMPSase &om E. coli may 
require both subunits for catalytic activity at physiological ligand concentrations and that this 
may be a general property of all AMPSases, regardless of source. AMPSase, however is not 
the only protein that changes its state of subunit association upon ligand binding. Briehl 
demonstrated that lamprey hemoglobin exists predominantly as monomers when oxygenated 
and as oligomers when deoxygenated (37). 
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This study focused on two residues of AMPSase, Asp"' and Argl43, which are 
involved in putative subunit-subunit interactions. Argl43 from one subunit hydrogen bonds 
to the 5'-phosphoryl group of IMP in the active site of the symmetry-related subunit (33). In 
addition, Arg hydrogen bonds to a backbone carbonyl of the juxtaposed subunit. Because 
Arg''*^ is conserved in all nine known sequences of AMPSase (8,24-29,31)^, we suggest that 
its role in the £. coli enzyme is also conserved in all other known AMPSases. The mutants 
R143L and R143K exhibit approximately the same kcat and values for aspartate as does 
wild-type AMPSase with small changes in the Km values for GTP (2- and 10- fold increase, 
respectively, for R143K and R143L). However, 100- fold increases in for IMP were 
observed for both mutant enzymes. Despite great differences in the hydrophobicity and 
electrostatic charge of lysine and leucine residues at position 143, they exhibit very similar 
kinetic properties in terms of IMP binding. 
The spatial relationship of the side chain of position 143 to the active site of the 
monomer related by the twofold symmetry is shown in Fig. 1. The guanidinum group of 
Arg'^ ^ bonds to the backbone carbonyl of the symmetry related subunit, as well as the S'-
phosphate of IMP (Ref 33 and Fig. lb). By model building, atom NZ of lysine 143 can 
occupy the same position as the guanidinum nitrogen responsible for the intersubunit 
hydrogen bonds (Fig. Ic). Thus, the increase in for the R143K mutant is not immediately 
obvious from the modeling study. However, the substitution of a lysyl for an arginyl side-
chain at position 143 leaves a packing void at the interface between monomers. Presumably 
this void is filled by a water molecule, in which case more than one conformational 
arrangement between that water molecule and the lysyl side chain is possible, but only one of 
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these arrangements is comparable to the interaction exhibited by Arg''*^ in the crystal 
structures. 
Asp , also conserved in known AMPSase sequences, forms an intersubunit salt 
bridge with the side chain of Lys'^ ° and a hydrogen bond to Arg'^ ^ through its backbone 
carbonyl. As for the R143K and R143L mutants, D231A showed about the same kca and 
for aspartate as wild-type AMPSase. However, Km values for GTP and IMP increased 20-
and 60- fold, respectively, relative to the wild-type enzyme. These results are qualitatively 
similar to those for the RI43K and RI43L mutants and are consistent with the hypothesis that 
the dimeric form of the synthetase is flmctionally active (11). The increase in for GTP 
with the mutants may be due to synergism in the binding of IMP and GTP. Markham and 
Reed, for instance, observed synergism in the inhibition of AMPSase by GDP and nitrate 
(38,39), both of which are competitive inhibitors with respect to GTP. Furthermore, on the 
basis of isotopic scrambling reactions (40), the y-phosphoryl group of GTP probably 
exchanges between the two sites, where it is either covalently linked to the 6-oxo group of 
IMP or covalently linked to the |3-phosphoryl group of the guanine nucleotide. In the absence 
of the dimer interface, AMPSase cannot provide an appropriate environment for binding 
IMP, which probably impairs the exchange process just described and leads to a weaker 
association of GTP with the enzyme. 
Combining the two Imes of evidence from biophysical analysis and initial rate 
kinetics on both the wild-type and mutant enzymes, we established a clearer relationship 
between the association states and enzymatic activity of E, coli AMPSase. MALDI mass 
spectroscopy revealed the existence of a 92-kDa species for ail the mutant en^rmes, 
indicating that mutations at positions 231 and 143 do not prevent dimerization. R143L, in 
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the presence of ligands, showed an apparent molecular weight of a dimer as determined by 
gel filtration analysis (data not shown). These observations suggest that neither Arg'^ ^ nor 
Asp '^ are essential for dimer formation. On the other hand, position 231 and 143 mutants 
studied here exhibit little change in values for the dimer to monomer equilibrium in the 
presence or absence of ligands, and higher Km(IMP) and Km(GTP) values with little change 
in values, implying that dimerization of AMPSase is required for the precise recognition 
and binding of substrates IMP and GTP. Assuming that the mutant ensues retain the rapid 
equilibrium random ter ter mecham'sm of wild-type AMPSase (1), the comparable values 
for the mutants and wild-type AMPSase suggest neither Arg''*^ nor Asp '^ play a role in the 
rate-limiting step of catalysis (interconversion from AMPSase-MgGTP '^-IMP-aspartate to 
AMPSase-adenylosuccinate-MgGDP'"-Pi). 
An interesting question concerns the significance of the AMPSase monomer-dimer 
equilibrium and its physiological implications, if any. The enzyme should exist primarily as 
a monomer in the ^M concentration range and substrates should shift the monomer-dimer 
equilibrium to dimer. Only if the monomer and dimer have dissimilar activities at 
physiological ligand concentrations can the monomer-dimer equilibrium be of significance to 
regulation. Interestingly, in the enzyme concentration range of 20 - ISO pM, there is a several 
minute lag in adenylosuccinate production when the reaction is initiated with the en^me 
(data not shown). When the ens^e is preincubated with MgGTP'^  and IMP and the reaction 
initiated with L-aspartate, however, the lag is eliminated. These findings are consistent with 
either an inactive monomer or a monomer of low activity relative to the dimer. Perhaps 
AMPSase is a monomer in the absence of nucleotide substrates, but is activated by novo 
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purine nucleotide biosynthesis. This scenario may represent a major control mechanism of 
adenylosuccinate biosynthesis. 
It is also noteworthy that AMPSase from Saccharomyces cerevisiae was identified as 
a single stranded DNA binding protein that specifically recognizes an autonomously 
replicating sequence (30). Because most of the single stranded DNA-binding proteins are 
oligomers, the dimerization phenomenon may indicate a dual role for AMPSase as an enzyme 
and as a regulatory element in DNA replication. 
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Table! 
Alignment of E. coli AMPSase amino acid sequence 138-148,228-233 with the sequences 




Bacillus substilis MDKAARIGIRl LDIDQGTY 24 
Dictyostelium dicoidium SSKASRGGLRV LDLDFGCY 25 
Escherichia coli EDKVARRGLRV LDIDHGTY 26 
Human liver SSKAARSGLRM LDIDFGTY 27 
Mouse muscle SSKAARTGLRI LDIDFGTY 28 
Mouse T-lymphoma cells SSKAARSGLRM LDIDFGTY 29 
Haemophilus Influenzae EDKVARRGLRV LDIDHGTY 30 
Brucella abortus EDKVGRRAIRV LDNDHGTY 31 
Saccharomyces cerevisiae STKASRSGLRV LDIDFGTY 32 
*The conserved residues coresponding to K140, R143, R147 and D231 in E. coli AMPSase 
from different sources are shown in bold character. 
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Table U 
Oligonucleotides used in site-directed mutagenesis and sequencing 




Sequencing primer for Residue 143: CTGTGTGAAGCATGTCC 
Sequencing primer for Residue 231: ATGGCTGTTGCCGACATC 
Underlined letters indicate the mismatches 
Table III 
Kinetic parameters of wild-type and mutant AMPSases from E. coif 
Protein kca$ V (GTL') J^(IMP) J^(ASP) KJ^(GTP) 1^ (IMP) 
(S-') (HM) (mM) (mM) (jiM) im 
Wild-type 1.00 ±0.05 26.2 ± 2.30 0.03 ± 0.00 0.23 ± 0.04 38.8 ± 6.40 74.1 ± 14.4 
RI43K 1.04 ±0.01 S8.3 ± 6.30 2.50 ±0.25 0.26 ± 0.05 31.0 ±5.92 1.50 ±0.34 
R143L 1.01 ±0.01 283 ± 26.2 2.79 ±0.13 0.34 ± 0.06 196 ± 37.6 1.26 ±0.25 
D231A 0.76 ± 0.02 503 ±41.3 1.31 ±0.23 0.50 ± 0.03 197 ± 62.3 20.4 ± 0.67 
'Experimental conditions as described in Experimental Proceduies. 
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Table IV 
Monomer-Dimer Dissociation Constants 
Enzyme •A2g0nm K<j' (Ajsonm) Goodness of Fit*^ 
In the absence of ligands 
Wild-type 0.3 0.464 11.2 0.030 
4.0 0.170 4.12 3.54 
R143K 0.3 0.452 10.9 0.777 
RI43L 0.2 0.394 9.53 0.849 
D231A 0.3 0.362 8.76 0.207 
In the presence of ligands 
Wild-type 0.4 4.26x10^° 1.03x10- '^ 0.00019 
R143K 0.4 0.178 4.31 1.96 
R143L 0.4 0.307 7.43 2.07 
D231A 0.4 0.208 5.03 0.151 
The dissociation constant in 280 nm absorbance units 
'^ e dissociation constant in |iM determined by equation (3) shown in "Experimental 
procedures." 
'^ Goodness of fit was determined by the x^test. 
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Fig. 1 a) Stereoview of the AMPSase dimer complexed with IMP 
b) Stereoview of the interaction of IMP with Argl43 
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Fig. 3 a) Typical sedimentation equilibrium distribution of AMPSase in the absence of 
ligands.b) Apparent molecular mass of AMPSase as a function of protein concentration (in 
A280iun) by the following equation; apparent molecular mass (in Da) = (S(hi c)/5r^) x 
(2RT/((1- up)co ). c, AMPSase concentration shown as units of absorbance at 280 nm; r, 
radial distance from center of rotor; T, temperature in Kelvin; ~u, partial specific volume; p, 
solution densiQr; o, angular velocity 
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CHAPTER III. AMBIGUITIES IN MAPPING THE ACTIVE SITE OF A 
CONFORMATIONALLY DYNAMIC ENZYME BY DIRECTED 
MUTATION: ROLE OF DYNAMICS IN STRUCTURE-FUNCTION 
CORRELATION IN ESCHERICHIA COU ADENYLOSUCCINATE 
SYNTHETASE' 
A paper published in the Journal of Biological Chemistry' 
Wenyan Wang^ Andrea Gorrell^, Zhenglin Hou^, Richard B. Honzatko^, and Herbert J. 
Fromm '^* 
ABSTRACT 
On the basis of ligated crystal structures, Asn '^, Asn^*, Thr''^ , and Arg*" are not 
involved in the chenucal mechanism of adenylosuccinate synthetase from Escherichia coli, 
yet these residues are well conserved across species. Purified mutants (Asp '^^ Ala, 
Asn '^->Ala, Asn^®-+Asp, Asn^*->Glu, Thr'*^-^Ala and Arg^"->Leu) were studied by 
kinetics, circular dichroism spectroscopy and equilibrium ultracentrifugation. Asp '^ and 
Arg '^^  are not part of the active site, yet mutations at positions 21 and 419 lower Acn 20-fold 
* This research was supported in part by Grants MCB-92I8763 and MCB-9316244 from the National Science 
Foundation and Grant NS I0S46 from the National Institutes of Health, United States Public Health Service. 
Joumai paper number /-17812 of Iowa Agriculture and Home Economics Experiment Station, Ames Iowa; 
Project No. 3191, and supported by Hatch Act and State of Iowa Funds. 
' Reprinted with permission frtim The Journal of Biological Chemistry (1998) 273,16000-16004. Copyright 
©1998 by The American Society for Biochemistry and Molecular Biology, Inc. 
 ^Three ^ wluate students and professors, respectively. Paper written by Wang and Gorrell with assistance from 
Hoozatko and Fromm. Mutations Asn"->Asp and Arg*"-»Leu, pH kinetics and ultracentrifugation of 
Asn"-»Asp performed by Gorrell. 
' To whom correspondence should be addressed: Dr. Herbert J. Fromm, Department of Biochemistry and 
Biophysics, Iowa State University, Ames, lA SOOI1 (Phone) (S15>294-4971. (Fax) (S1S>294-04S3, email: 
hjfromm(giastate.edu 
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and lO-fold, respectively. Thr^^ interacts only through its backbone amide with the guanine 
nucleotide, yet its mutation to alanine significantly increases Km for all substrates. Asn^^ 
hydrogen bonds directly to the 5'-phosphoryl group of IMP, yet its mutation to alanine and 
glutamate has no effect on Km values, but reduces kca by 100-fold. The mutation 
Asn '^->Asp causes 10- to 57-fold increases in Km for all substrates along with a 30-fold 
decrease in A^at- At pH 5.6, however, the Asn '^-^Asp mutant is more active, yet binds IMP 
100-fold more weakly, than the wild-type enzyme. Proposed mechanisms of ligand induced 
conformational change and subunit aggregation can account for the properties of mutant 
enzymes reported here. The results underscore the difficulty of using directed mutations 
alone as a means of mapping the active site of an enzyme. 
INTRODUCTION 
Adenylosuccinate synthetase (IMP:L-aspartate ligase (GDP forming) E.C. 6.3.4.4, 
AMPSase^) is an essential enzyme in most organisms (for review, see reference 1), 
catalyzing the first committed step in the biosynthesis of AMP: 
IMP + L-aspartate + OTP •«» adenylosuccinate + GDP + phosphate 
Primary sequences of AMPSase (2-10) are 40% identical for any pairwise comparison, 
indicating a strong tendency to preserve a primordial gene throughout evolution (10). The 
enzyme putatively facilitates the formation of 6-phosphoryl-IMP by the nucleophilic attack 
of the 6-0X0 group of IMP on Y-phosphate of GTP, and then the formation of 
adenylosuccinate by displacement of the 6-phosphoryl group by L-aspartate (11,12). 
^Abbreviations used are: AMPSase, adenylosuccinate synthetase; ASP, L-aspartate; KPj, potassium phosphate 
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AMPSase from Escherichia coli is a monomer at physiological concentrations (I ^M), but 
dimerizes when nucleotide ligands are present (13,14). The dimer is probably the 
physiologically active form of the enzyme, having a Km corresponding to intracellular 
concentrations of IMP. 
The disordered active site of unligated AMPSase becomes ordered in the presence of 
substrates and substrate analogs (15-20). The largest conformational change is a 9 A 
movement of the loop 42-53 (40s loop), which folds against the guanine nucleotide. Loop 
120-131 (120s loop), which interacts with IMP, and loop 299-303 (300s loop), which 
interacts primarily with analogs of L-aspartate in crystal structures, become ordered in the 
presence of ligands. The conformational changes above putatively exemplify induced fit, a 
concept introduced by Koshland some three decades ago (21). The ligand-enzyme 
interactions, however, which contribute most (in terms of a thermodynamic driving force) to 
the observed conformational changes have yet to be identified, nor can we exclude the 
possibility of energy contributions from interactions between protein residues well-removed 
from the active site. 
On the basis of ligated crystal structures of adenylosuccinate synthetase, Asp '^, Asn^^, 
Thr**^ and Arg '^^  do not interact with atoms of substrates involved with the chemistry of 
phosphotransfer or nucleophilic attack by L-aspartate (17,19). In fact, Asp '^ and Arg '^^  do 
not interact with ligands (16,17,19,20). The backbone amide of Thr^^ forms a hydrogen bond 
with the a-phosphoryi group of the guanine nucleotide, but its side chain forms only a weak 
hydrogen bond to that same a-phosphoryl group (20). Asn '^ provides one of 5 hydrogen 
bonds to the 5'-phosphoryl group of IMP; implicating Asn '^ in the ground-state stabilization 
of the IMF-enzyme complex (17,19). Nevertheless, mutations of Asn '^, have little effect on 
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the Km of IMP, but a major impact on kcat, mutations of Asp '^ and Arg '^' destabilize the 
transition state, and the mutation of Thr'*^ to alanine reduces affinities for all substrates. The 
effects of each of the mutations above can be understood in terms of their influence upon two 
interdependent, dynamic mechanisms in AMPsase; (i) ligand induced reorganization of the 
active site and (ii) ligand induced dimerization of the enzyme. The above mutations also 
illustrate the importance of a sound understanding of structure and dynamics of an enzyme 
before assigning functional roles to side chains. 
EXPERIMENTAL PROCEDURES 
Materials— GTP, IMP, L-aspartate (ASP), phenylmethylsulfonyl fluoride, and bovine serum 
albumin came from Sigma. Restriction enzymes came from Promega. Pfii DNA polymerase 
and £1 coli strain XL-1 blue were obtained from Stratagene. E. coli strain H1238 (purA') was 
a gift from Dr. D. Bachman (Genetic Center, Yale University). Phenyl Sepharose CL-4B 
came from Pharmacia. Other reagents and chemicals came from Sigma if not otherwise 
specified. 
Overexpression of wild-tvpe and mutant AMPSases— Due to the undetectable levels of 
expression for some mutants using the PMS204 plasmid expression system, we used here a 
more efficient prokaryotic expression system, based on the pTrc99A vector (Pharmacia). 
The pur A gene was amplified by PGR using the following primers to incorporate Nco 
I and Pst I restriction sites at either end of the pur A gene. 
TrcN 5'-GATGCCATGGGTAACAACGTCGTCG-3' {Ncol site underlined) 
TrcC2 S'-AACTGCAGTCTGCCAGGCGTACCACA-3' ijPstl site underlined) 
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The Ncol restriction site was incorporated into the N-terminus of the purA gene, before the 
first Met codon (ATG), and the Pstl restriction site was introduced after the stop codon. PJu 
DNA polymerase was used in the PGR reaction to ensure high-fidelity amplification (Fig 1). 
The amplified and subcloned ptirA gene containing the 1.3 kb fragment was 
sequenced twice in both directions using the chain termination method (22) at the Nucleic 
Acid Facility, Iowa State University. Sequence analysis showed 100% identity with the £. 
coli pur A sequence deposited in GENBANK, except at position 415, a GAT (Asp) is 
replaced by (JGT (Gly), which agrees with published crystal structures (IS). The pur A gene 
was subcloned into the pTrc99A vector and the final construct, pTrpA, was transformed into 
E. coli strain H1238 (purA') for overexpression of AMPSase. 
Site-directed mutagenesis— The Ncol - Pstl fragment containing pur A was subcloned in to 
the pAlterEXII vector (Promega). Site-directed mutagenesis was carried out according to 





5'.CGCAGGCCATGCTCTCGTAATCAA-3' (Thr^^->Ala), and 
5'-CCGGATCTTACiaAAACCATG-3'(Arg^"-»Leu) 
where the underlined bases are mismatched with respect to the wild-type purA sequence. 
The primer 5'-AACAACGTCGTCGTACTGGG-3' was used to sequence the plasmids and 
confirm mutations for all but Arg^"-^Leu, where the primer 5'-
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AACAGCCAAGCTTGCATGCC-3' was used. All primers were synthesized on a 
Bioresearch 8S70EX automated DNA synthesizer at the Nucleic Acid Facility at Iowa State 
University. After mutagenesis, the Ncol - Pstl fragment containing the desired mutation was 
subcloned into pTrc99A and transformed into the E. coli strain HI238 {pur A') for 
expression. 
Preparation and kinetics of wild-tvpe and mutant AMPSases^— The wild-type and mutant 
enzymes were purified as described elsewhere (23-25) with the following modifications. The 
enzyme was eluted fix)m a phenyl sepharose CL-4B column by a series of buffered solutions, 
0.6 M, 0.4 M and 0.2 M in (NH4)2S04 and 50 mM in potassium phosphate (KPj) (pH 7.0). 
All the enzymes eluted at 0.2 M (NH4)2S04. The enzyme fractions were concentrated and 
dialyzed against 50 mM KPi (pH 7.0), then further purified using a DEAE-TSK HPLC 
column. Enzyme purity was monitored by SDS-PAGE (26), and protein concentrations were 
determined using Bradford reagent (Bio-Rad) (27). All the mutant enzymes were subjected 
to circular dichorism analysis as described elsewhere (22-24). From 1-500 ^g/mL enzyme 
was used in kinetic assays, depending on the activity of each mutant. Absorbance changes at 
290 nm and 25''C were monitored with a GBC model 918 UV/visible spectrophotometer 
equipped with a Peltier-Effert temperature controller. 
pH effects on AMPSase activity— MES and HEPES were chosen as buffers for the pH range 
5.5 - 8.5, and acetate buffer was used at pH 5.2. Buffer concentrations were held at 20 mM 
for all assay solutions. Assay solutions contained 300 ^M GXP, 5 mM MgCh, 5 mM ASP 
for the wild-type enzyme and 1.5 mM GTP, 7 mM MgCh, 10 mM ASP for the Asn '^->Asp 
mutant enzyme. IMP concentrations varied fixim 25-750 ^M for assays of the wild-type 
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enzyme, and 25 to 10 mM for assays of the Asn '^->Asp mutant. 500 ug/mL of the 
Asn '^->Asp mutant and 1 ng/mL of wild-type AMPSase were used in assays. 2 mm quartz 
cuvettes were used to compensate for the high absorbance due IMP. Longer assay time (4 
min) was used to compensate for the low activity of the Asn^®->Asp mutant. 
Analytic equilibrium sedimentation ultracentrifueation— Wild-type, Asn '^-^Asp and 
Asn^"->GIu mutant AMPSases were analyzed by analytical equilibrium sedimentation 
ultracentrifugation, in the absence and in the presence of ligands (5 mM MgCh, 30 ^M IMP, 
30 ^M GTP, 1 ^M hadacidin) at pH 7.7 and 5.6. Equilibrium ultracentrifugation 
experiments were performed as described previously (13), using hadacidin in place of 
aspartate. Enzyme concentrations were such that they gave an ODjgo reading of 0.4. 
Monomer-dimer dissociation constants were determined as previously described (13). 
RESULTS 
Sequence comparison and crvstalloeraphic analvsis^— Positions corresponding to Asp^i, 
Asn38, His^^ Thr^2 anj Arg^" are almost 100% identical across species (Table I). In the 
absence of ligands Asn '^ has no specific interactions, but in the ligated synthetase it 
hydrogen bonds with the 5'-phosphate of IMP [Fig. 2; (17)]. His^^, a putative catalytic acid 
(17,28), has three mutually exclusive sets of interactions: (i) In the unligated synthetase His '^ 
hydrogen bonds with Asp^* (16,17). (ii) In the complex of GDP, NO3*, IMP, Mg^"^, and 
hadacidin, His '^ hydrogen bonds with the p-phosphoryl group of GDP (17). (iii) In the 
complex of GDP, 6-thiophosphoryI-IMP, Mg^^ and hadacidin, His '^, hydrogen bonds with 
the 6-thiophosphoryI group and to Glu '^ (19). Asp '^ in the unligated synthetase hydrogen 
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bonds with Mis'", as noted above, but also makes a salt link with Arg '^^  in ligated complexes 
(17). Thr'*^ has no specific interaction in the unligated synthetase (16, 17), but in ligated 
complexes its backbone amide interacts with the a-phosphoryl group of GDP and its 
backbone carbonyl hydrogen bonds with a water molecule, which in turn hydrogen bonds 
with the 2'-0H of GDP and backbone carbonyl 417. In one of three ligated complexes of the 
synthetase (17,19,20), the side chain of Thr"^ may interact weakly with the a-phosphate of 
GDP [oxygen to oxygen, donor-acceptor distance of approximately 3.1 A (20)]. The 
interactions above are summarized in Table II. 
Expression, purification, and characterization of wild-tvpe and mutant AMPSases—All 
proteins have an apparent monomer molecular mass of 48 kDa and purity greater than 95% 
as shown by SDS PAGE. pTrpA plasmids containing the mutations of this study 
complement the pur A' auxotroph on M9 minimal medium, supplemented with thronine and 
arginine, indicating sufficient enzyme activity to sustain the transformed cells. 
Secondary structure analysis—The CD spectra of Asp '^^ Ala, Thr''^ ->Ala, Arg'"'->Leu 
and wild-type enzymes are identical from 200 to 260 nm, indicating the absence of 
conformational change due to mutation. The position 38 mutants showed small differences 
in their CD spectra relative to the wild-type spectrum (data not shown). The dififerences are 
probably a consequence of a perturbation in the conformation of the 40s loop and/or the 
monomer-dimer equilibrium of AMPsase (see below). 
Kinetic analysis of wild-tvpe and mutant enzvmes— The Km values of the Asp '^-»Ala, 
Asn '^-^Ala, and Asn '^->Glu mutants are comparable to those of wild-type AMPSase (Table 





Km values showed 5-to 10-fold increases. The mutation of Asp '^ to alanine reduced Acat 20-
fold and slightly increased and while Arg'*" reduced ken lO-fold, with a 
slight increase in and 8-fold increases in and Asn '^->Ala, Asn^*->Asp 
and Asn^*-»Glu mutants showed 30- to 200-fold reductions in Km relative to the wild-type 
enzyme. Of the three position Asn '^ mutants, only Asn^*->Asp exhibited increased 
values increased 80-fold). 
pH dependent kinetic studies of wild-tvpe and Asn -*Asp—Of the three position 38 
mutants, only Kf^ values for the Asn '^->Asp mutant show large increases. Altered kinetic 
parameters for the Asn '^->Asp mutant could originate firom electrostatic repulsion between 
the S'-phosphoryl group of IMP and the side chain of Asp^^. Protonation of the Asp^^ side 
chain, or the S'-phosphoryl group of IMP, then, could restore k^M and Kf^ to wild-type levels. 
kai versus pH profiles for the wild-type and the Asn '^->Asp enzymes are bell-shaped (Fig. 
3). The optimum pH for wild-type and Asn ->Asp enzymes is 7.8 and 5.6, respectively. In 
fact, the Asn '^->Asp mutant had higher catalytic activity than the wild-type enzyme at pH 
5.6 (Table III) and 5.2 (data not shown). Although wild-type levels of activity were 
recovered in the Asn '^->Asp mutant by dropping the pH, remains 100-fold higher than 
that of the wild-type enzyme. 
Analytic equilibrium uitracentrufueation— IMP induces dimerization of AMPsase 
monomers (13,14). Furthermore, the dimer arguably has 100-fold higher affintiy for IMP 
* 
than the monomer. Hence, we examined the Asn '^-^Asp mutant by ultracentrifiigation 
methods, in order to determine whether its elevated originated from its properties of 
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aggregation. In centrifugation studies reported here, the wild-type and Asn^^->Glu enzymes 
are controls, as each exhibits comparable Km values for IMP, and hence should be dimers in 
the presence of IMP. The monomer-dimer dissociation constants for the three enzymes in 
the absence and presence of ligands at pH 7.7 are in Table IV. At pH 5.6, the three enzymes 
precipitated during ultracentrifugation runs. The three AMPSases show similar Kq values in 
the absence of ligands. In the presence of ligands, however, the Ko of the Asn^^->Asp 
mutant (252 ^M) differs significantly from that of wild type and Asn '^-+Glu enzymes, both 
of which are vanishingly small (Table IV)- Furthermore, the dissociation constant for 
Asn '^-^Asp in the presence of ligands is 19 times higher than the dissociation constant for 
Asn '^->Asp in the absence of ligands. 
DISCUSSION 
For the rapid-equilibrium mechanism of AMPSase (1), represents the breakdown 
of the quartemary complex of enzyme and substrates to emqone and products. Thus, kca for 
AMPsase is sensitive to the energy changes in the transition state. Kinetic data indicate 
destabilization of the transition state for the Asp '^-^Ala and Arg '^^ ->Leu mutants (keg, falls 
20- and 10-fold, respectively, relative to the wild-type enzyme). Thus, the Asp '^-Arg*" salt-
link must stabilize the transition state. As the hydrogen bond between Asp '^ and Arg^*^ is 
about 13 A from the bound Mg^*** (approximate center of catalysis), the stabilization is 
necessarily due to an indirect mechanism. The loss of the Asp '^-Arg^*^ salt-link could 
destabilize interactions between the 40s- and 400s-loop. Indeed, in the unligated enzyme 
Arg '^' is disordered (15,16) and the 40s- and 400s-loop do not interact. In the ligated 
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enzyme backbone carbonyl 417 hydrogen bonds with a water molecule, which in turn 
hydrogen bonds to backbone carbonyl 42 and the 2'-0H of GDP (17). 
An alternative mechanism by which the loss of the Asp '^-Arg '^^  salt-link could 
influence the transition state is by way of a small perturbation of the P-loop (residues 8-16). 
Asp'^  is a putative catalytic base (17,28). A displacement of its side chain by perhaps as 
little as 0.5 A could lead to complete inactivation of the synthetase. The interaction of Asp '^ 
with Arg'*'^  could stabilize the position of helix HI, which lies on the C-terminal side of the 
P-ioop. Mutations in the P-loop have only modest effects on K„^ and no effect on the Km 
for other substrates (28), consistent with the lack of change in Km values for the Asp '^->Ala 
mutant. 
The mutation of Arg '^^  to leucine has a minor effect on the Km values for IMP and 
GTP. The increased Km^ must be due to a localized change in the 400's loop as the Asp '^ 
mutation has no effect on Km values. The mutation of Arg '^^  could perturb the stacking of 
Pro '^^  with the guanine base and hence lead to the increase in Km^- Given the observed 
binding synergism of IMP and GTP (13), a reduced GTP interaction should weaken IMP 
binding. 
The side chain of Thr*^ binds weakly (at best) to the a-phosphoryl group of GTP, yet 
it is a conserved residue and its mutation to alanine increases Km values by approximately 
10-fold. The above phenomenon may be a consequence of the 40s-loop, which is in an 
equilibrium between two conformational states. The "open" conformer predominates in the 
absence of Ugands, whereas the "closed" conformer appears when ligands are bound to the 
active site. The absence of an appreciable effect on ktm. due to the mutation of Thr^^ to 
alanine implies no significant perturbation of the 40s-loop in the ligated conformation of the 
i 
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synthetase. If however, the mutation to alanine stabilizes the "open" conformation of the 
loop, then ligands must spend a greater fraction of their binding energy to drive the 40s-loop 
to its "closed" conformation. That the values increase for all substrates is a reflection of 
synergism in substrate binding (13). 
Asn '^-^Ala and Asn '^->Glu have no influence on Km values but reduce by 200-
and 30-fold, respectively. Evidently, the interaction between Asn '^ and the 5'-phosphate of 
IMP does not enhance the affintiy of IMP for the active site. Instead the binding energy 
probably is diverted completely to the stabilization of the transition state. Asn '^ belongs to a 
short element (residues 38-41) which immediately precedes the 40s-loop. Within this 
structural element, the peptide link between residues 40 and 41 undergoes a significant 
change in conformation (17) and the a-carbon and side-chain of Asn move toward the 5'-
phosphate by 1 A. These small conformational adjustments preceding the 40s-loop are 
probably coupled to the 9 A movement of the loop itself. Hence the energy of interaction of 
Asn '^ with the 5'-phosphate of IMP, may go to support the conformational change in the 
40s-loop. 
The mutation of Asn '^ to aspartate presents a far more complex phenomenon. The 
introduction of a negative charge at position 38 probably elevates kJ^^ by charge repulsion. 
All of the allowable confoimations of Asp^* bring its side chain close to the S'-phosphate of 
IMP. (In contrast, allowable conformations of Glu '^ are possible which bring about 
significant separation of the S'-phosphate and the side chain). By protonation of Asp '^and^r 






for the mutant at pH 5.6 is restored to wild type levels, possibly because IMP can again drive 
the required conformational change in the 40s-loop. 
Km values for the Asn '^->Asp mutant are not restored to wild-type levels at low pH 
however, suggesting that a pH-independent mechanism is responsible for the elevated Km 
values of the mutant. The wild-type enzyme is predominantly a monomer in the absence of 
ligands at concentrations used in assays (13). Furthermore, IMP induces dimerization of the 
wild-type enzyme at pH 7.7; its interaction with Arg'^ ^ of a second monomer being essential 
in stabilizing the dimer. The mutation of Arg'^ ^ to leucine or lysine does not influence 
but increases Km^^ 100-fold at pH 7.7, and concomitantly abolishes ligand-induced 
dimerization at low concentrations of IMP and enzyme (13). The high kJ^^ values for the 
Asn '^->Asp mutant at pH 7.7 then may reflect the weak interaction of IMP with the mutant 
as a monomer, rather than the binding of IMP to a mutant dimer. This is supported by the 
monomer-dimer dissociation constants for Asn ->Asp with and without ligands. The higher 
dissociation constant for the Asn '^->Asp in the presence relative to the absence of ligands 
shows that Asn '^->Asp favors a dimeric state in the absence of ligands. At pH 5.6 IMP may 
bind to the active site of the mutant as a monoanion, allowing formation of the hydrogen 
bond with the side chain of Asp '^. However, the monoanionic state of IMP may not stabilize 
sufficiently its interaction with Arg'^ ^ of a second subunit. Hence, the affinity for IMP 
remains low, because the mutant remains a monomer at low pH. The wild-type enzyme, on 
the other hand, selects the dianion state of IMP from solution at low pH and, as a 
consequence, dimerizes. Hence, the for wild-type en^rme at pH 5.6 reflects the 
interaction of IMP with a synthetase dimer. 
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AMPsase is rife with ligand-induced changes, which in a broad perspective influence 
subunit dimerization and/or reorganization of its active site. As a consequence of the 
coupling of ligand-binding energy to dynamic processes which influence the conformation of 
loci remote from the active site, residues can bind directly to substrates and have no effect on 
binding affinity as measured by Km and residues remote from the active site can have 
substantial effects on the stability of the transition state or the binding affinity of substrates. 
Such phenomena underscore the pitfalls in using site directed mutations alone in assigning 
residues to the active site of an enzyme. 
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Table III 
Kinetic parameters of wild-type and mutant AMPSases 
AMPSase PH kcm K OTP K IMP K ASP 
•^m *cat^ m'^  ^cat^ m^ '^* 
(s') (MM) (HM) (mM) (s ' HM ' XIO ') (s ' nM ' xlO') (s ' mM ') 
wild-type 7.7 I.OO±O.OS 2612 2811 0.2310.04 3814 3613 4.410.8 
S.6 0.096±0.008 111! 70120 0.910.2 911 1.410.4 0.1110.03 
Asp''-*Ala 7.7 0.049±0.001 52dt5 4814 0.1710.01 0.9510.09 1.0210.08 0.3010.02 
Ai8;*"-+Leu 7.7 0.I00±0.002 2S0120 200110 0.3410.07 0.4110.03 0.4910.03 0.2910.06 
Asn"->Ala 7.7 0.0048±0.0002 4115 4917 0.3010.02 0.1210.02 0.1010.01 0.0I610.00I 
Asn '^-tAsp 7.7 0.013410.0003 270120 16001400 2.610.4 0.05110.004 0.00810.002 0.005210.0007 
S.6 0.17110.008 116110 38001400 0.510.1 1.510.2 0.0451.002 0.3310.09 
Asn'*-»Glu 7.7 0.03410.001 5415 2811 0.2410.02 0.6210.06 1.2210.06 0.14310.01 
His*'->Asn' 7.7 0.009S10.0001 130110 40018 2.010.6 0.07610.008 0.02410.002 0.00510.002 
NIR**->Ala 7.7 0.89010.02 280i20 12315 1.410.1 3.210.2 7.210.3 0.6510.05 
'From Kang, C, Sun, N., Poland, B. W., Gonell, A., Honzatko, R. B., and Fromm, H. J. (1997) J Biol. Chem. 272,11881 • 1188S 
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Table IV 
Monomer-dimer dissociation constants for wild-type and mutant AMPSases 
Absence of Ligands Presence of Ligands 
AMPSase KD(HM) Goodness of fit' KD(tiM) Goodness of fit' 
Wild-type 15±2 0.0009 0± 0.00006 0.2287 
Asn^*-^Asp 14±2 0.6014 250 ± 70 1.130 
Asn '^^ Glu 24±4 2.187 0± 0.0005 3.278 
"Goodness of fit determined by the chi-square test (29) 
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Figure 2. Stereoview of conformational changes in the active site of AMPsase. 
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(nonnalized) vs pH 












Figure 3. kou versus pH profiles of wild-type and Asn '^->Asp mutant 
AMPsase. The kt^ values for both enzymes were normalized for clarity of 
comparison. The maximum k^u value is 1.59 s*' for the wild-type enzyme at 
pH 7.8, and 0.237 s*' for Asn '^->Asp mutant enzyme at pH 5.6. 
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CHAPTER IV. DIRECT AND INDIRECT DETERMINANTS OF 
SUBSTRATE RECOGNITION IN ESCHERICHIA COU 
ADENYLOSUCCINATE SYNTHETASE* 
A paper prepared for the Journal of Biological Chemistry 
Andrea Gorrell^^, Wenyan Wang^, Zhenglin Hou^, Richard B. Honzatko^ 
and Herbert J. Fromm '^ 
ABSTRACT 
A collection of P-branched amino acids in the active site of adenylosuccinate 
synthetase from Escherichia coli exhibit a remarkable variation as to the degree and 
mechanism by which they influence substrate recognition and catalysis. Perturbations in the 
steady-state kinetics caused by directed mutations of Thr'^ *, Thr'^ ', Val '^^ , Thr'"®, and ThP®', 
reflect the stabilization of enzyme-substrate complexes by direct hydrogen bonding, by 
limitation of conformational flexibility in the protein, and by limiting nonproductive 
conformations of bound substrates. Thr'^ ' and TW®' hydrogen bond directly to IMP and L-
aspartate (ASP), respectively. Mutations of each residue to alanine either completely 
* This research was supported in part by Research Grant NS10S46 from the National Institutes of Health, by the 
United States Public Health Services, and by Grants MCB-9218763 and MCB-9316244 from the National 
Science Foundation. 
 ^Three graduate students and professors, respective .^ Paper written ^  Gorrell and Wang with the assistance 
of Honzatko and Fronun. Mutations Thr'^ AIa, Thi^ 'Val, and all Val mutants prepared and kinetics 
performed by Gorrelh 
i To whom all correspondance should be addressed: Dr. H. J. Fromm, Department of BiochemisHy and 
Biophysics, Iowa State Unlvenity, A,nies lA SOOl 1 Phone: (SIS)294-497I Fax: (S1S)294-04S3 email: 
67 
inactivate the synthetase (Thr''"->Ala) or increase the Km for IMP by 30-fold. Mutation of 
Thr'^  to alanine increases the Km for ASP by 30-fold, but the effect is indirect, as the 
mutation of Thr^"^ to valine reduces the Km for ASP by only 3-fold, and yet increases by 
300% relative to wild-type enzyme. Similarly, the mutation of Thr'^ ' to alanine increases the 
Km for IMP by 10-fold due to a perturbation in hydrogen bonding between Thr'^ ^ and IMP. 
Val^^^ can interact with ASP only through non-bonded contacts, yet its mutation to alanine, 
threonine or asparagine causes 35-, 15- and 40-fold incrrases in the Km of ASP. Inhibition of 
the wild-type and position-273 mutant enzymes by succinate, fumarate and maleate is 
consistent with Val^^^ acting sterically to block nonproductive complexes of dicarboxylic 
acids with the active site. Factors which maintain the strict conservation of Val^^ across all 
known adenylosuccinate synthetases are discussed. 
INTRODUCTION 
In a broad range of organisms and cell-types, adenylosuccinate synthetase (IMP:L-
aspartate ligase (GDP forming) E.C. 6.3.4.4, AMPSase') plays a significant role in de novo 
purine synthesis, the purine nucleotide cycle, and/or salvage pathways for nucleotides (for 
reviews see (1-3)). AMPSase converts IMP and L-aspartate (ASP) to adenylosuccinate using 
GTP as an energy source. The synthetase from Escherichia coli is a homodimer (4). IMP 
may play an important physiological role in the regulation of synthetase activity by stabilizing 
the assembly of inactive monomer into active dimers (2,5,6). As indicated by investigations, 
first in kinetics (7-11) and then in X-ray crystallography (12-14), the catalytic mechanism 
' Abbreviations used: AMPSase, adenylosuccinate synthetase; CD, circular dichroism; ASP, L-aspaitate. 
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involves a nucleophilic attack on the y-phosphoryl group of GTP by the 6-oxo group of IMP 
to form a 6-phosphoryl intermediate of IMP. The displacement of that 6-phosphoryl group 
by the amino group of ASP generates adenylosuccinate. The synthetase enforces strict 
determinants for substrate specificity; only 2'-deoxy-IMP and p-D-arabinosyl-IMP substitute 
for IMP, 2'-deoxy-GTP and GTPyCS) for GTP, and DL-threo-P-fluoroaspartate, alanine-3-
nitronate, cysteine suifinate, L-aianosine, and hydroxylamine for ASP (7,15-17). 
Three loops, residues 40—52, 120—130, and 298—^304, undergo conformational 
transitions in response to active site ligands (13,18-20). Directed mutations of residues in or 
near Loop 40—^52 have generated unanticipated results. Asn '^ in all ligated crystal structures 
of the synthetase, for instance, hydrogen bonds with the 5'-phosphoryl group of IMP. Yet, 
the mutation of Asn '^ to alanine has no effect on the Km for IMP, but reduces kau by three 
orders of magm'tude (21). Evidently, the energy associated with the Asn '^-IMP interaction 
goes entirely toward the stabilization of the transition state. Hence, a crystal structure by 
itself does not reveal the extent to which interactions stabilize the transition state as opposed 
to the ground state of enzyme-substrate complexes. 
Recent crystal structures and/or the sequence conservation amongst adenylosuccinate 
synthetases implicate Thr'^ *, Thr'^ ', Val '^^ , Thr^"®, and Thr'®' in important fimctional roles. 
All of the above residues except Val^^^ belong to flexible loops, which undergo significant 
conformational change in response to the binding of IMP (Loop 120—130) or ASP (Loop 
298—^304). Val^^^ is conserved in all known sequences of AMPSase, yet on the basis of 
crystal structures, has no obvious role in structural stability or in the recognition of substrate. 
Directed mutation, steady-state kinetics and circular dichroism (CD) spectroscopy reveal the 
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extent to which these residues contribute to the stability of the transition state and/or to the 
binding affinity of substrates. We report here a remarkable variation as to the degree and 
mechanism by which this set of p>branched residues influence substrate recognition and 
catalysis by adenylosuccinate synthetase. 
EXPERIMENTAL PROCEDURES 
Materials— Restriction engines came from Promega. PJu DNA polymerase and £. 
coli strain XL-I blue were obtained from Stratagene. £. coli strain H1238 (purA~) was a gift 
from Dr. D. Bachman (Genetic Center, Yale University). Phenyl Sepharose CL-4B came 
from Pharmacia, and hydroxylamine hydrochloride from Fisher Scientific. Other reagents 
and chemicals came from Sigma, unless specified otherwise. 
Expression of wild-tvpe and mutant enzvmes— Details regarding the construction of 
pTrpA are in the literature (21). The ptw A gene in PMS204 was amplified using PCR and 
Pju DNA polymerase, and subcloned into pTrc99A (Pharmacia). The resulting plasmid 
(pTrpA), was transformed into E. coli strain H1238, which cannot express the endogenous 
synthetase (purA~). 
Directed mutations—The Ncol—Pstl fragment containing/niM was subcloned into 
pAlterEXn (Promega). Site directed mutagenesis followed the protocol provided by Promega, Inc. 
The following primers were used in directed mutations: 
5'- AGCGATCGGCGCCACCGGTCG-3' for Thr'^ '-+AIa, 
5'- CGATCGGCACCGCCGGTCGTGGT -3* for Thr'^ -^Ala, 
5'- ACTCCACTCGTGeAGGTGCAGGTC-3' for Val '^^ -^AIa, 
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5'- ACTCCACTCGT^AGGTGCAGGTC-3' for Val"^-^Thr, 
5'- ACTCCACTCGTAATGGTGCAGGTC-3' for Val"^->Asn, 
5'- GAATTCGGCGCAGCTACGGGGCG-3' for Thr^°®-»Ala, and 
5'. TTCGGCGCAACTGCGGGGCGTCG-3' for Thr^°'->Ala. 
Nucleotide residues underlined above are mismatched with respect to the wild-type sequence. The 
sequencing primer used to confirm mutations at positions 128 and 129 was S'-
TCTGAAGCATGTCCGCTGATC-3', and that used for mutations at 273,300 and 301 was 5'-
CTGCTGGATATCGACCACGG-3'. Oligonuceotide syntheses and DNA sequences (dideoxy dye 
termination protocol) were done by the Nucleic Acid Facility, Iowa State University. The Nco\— 
Pstl Segment with the desired mutation, was subcloned into pTrc99A, and transformed into £. 
coli, pur A- strain H1238 for expression. 
Preparation of wild-tvpe and mutant AMPSases— Wild-type and mutant ens^mes 
were purified as described elsewhere (22-24) with the following modifications. The phenyl 
sepharose CL-4B column was washed in succession with solutions of 0.6,0.4 and 0.2 M 
(NH4)2S04 , buffered by SO mM IG^j, pH 7.0. Wild-type and mutant synthetases eluted from 
the column m 0.2 M (NH4)2S04. Appropriate fractions were pooled, concentrated and 
dialyzed against SO mM KPi, pH 7.0, then further purified by DEAE-TSK HPLC 
chromatography (Toso-Haas). Enzyme purity was monitored by SDS-PAGE (2S), and 
concentrations were determined by the Bradford method (26), using the reagent from Bio-
Rad. CD spectra for mutant and wild-type synthetases were taken as described elsewhere(22-
24). 
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Kinetic assays usine L-aspartate— Kinetic parameters of wild-type and mutant 
AMPSases were determined at 25° C by monitoring absorbance changes at 290 nm with a 
GBC Scientific Equipment model 918 GBC UV/visible spectrophotometer, equip[)ed with a 
Peltier-Effert temperature controller. Enzyme assay solutions contained 20 mM Hepes, pH 
7.7, S mM MgCh, and fixed concentrations for two of the three substrates, as appropriate, in 
the determination of ATm for the remaining substrate (11). Fixed concentration of GTP, IMP 
and ASP were 0.30,0.50 and 5.0 mM, respectively. 1—^200 ^g/mL of wild-type or mutant 
enzyme was used in each assay, depending upon its specific activity. Detennination of ken 
and Km values employed the program ENZFITTER (27). 
Determination ofK for inhibitors— The inhibition constants for succinate, fumarate, 
and maleate were determined utilizing a 5 X 5 matrix of substrate and inhibitor for each 
enzyme/inhibitor combination. Assay contained 20 mM HEPES, pH 7.7,5 mM MgCb, 500 
^M IMP, and 300 |iM GTP. Enzyme concentrations were 4 ^g/mL wild-type, 30 ^g/mL 
Val"^->Ala, 20 mg/mL for Val '^^ ->Asn, 66 mg/mL Val '^^ -^Thr. Aspartate was varied from 
fiom 0.5 to 5X Km (depending upon mutant examined) and inhibitor concentrations were 0 -
15 mM succinate, 0-16.7 mM fumerate, or 0 -10 mM maleic acid. All inhibitors were 




, KJ (Eq-1) 
was performed by linear regression analysis utilizing the MINITAB program (28). In 
Equation 1, v is the initial velocity, Vmax is the maximal velociQr, A is the ASP 
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concentration, I is the inhibitor concentration, K. is the Michaelis constant for ASP, Kj is the 
dissociation constant for the inhibitor, and Kj. is the dissociation constant for ASP. 
Kinetic assays usin  ^hvdroxvlamine (NH^OH)— 3 M NH2OH was freshly made from 
solid hydroxylamine hydrocholoride, and adjusted to pH 7.7 by the addition of potassium 
hydroxide. UV difference spectra of the reactions were recorded at 25® C on a GBC UVA^S 
918 spectraphotometer, equipped with a Peltier-EfTert temperature controller. The reaction 
solution contained 20 mM Hepes (pH 7.7), 1 mM GTP, 450 IMP, 6 mM MgCl2 and 400 
mM NH2OH, with 20 ^g/mL of wild-type or mutant enzyme. The spectra obtained at time 
zero was subtracted from the spectra collected at subsequent time points (Fig. 1). The 
AXgiax ^ difference spectra occurred at 270,264 and 270.5 nm, in the presence of ASP, ASP 
with excess adenylosuccinate lyase, and NH2OH, respectively. Recorded spectra were 
consistent the formation of 6-N-hydroxy-AMP, when hydroxylamine was used in place of 
ASP (7). Kinetic assays were conducted at 290 nm, using 2 mm quartz cuvettes to offset 
strong absorbance due to GTP at 280 nm. At 290 nm the extinction coefHcient the 
conversion of one mole of IMP into product is 3.51 x 10^. 
RESULTS 
Conservation of target residues—Thr'^ ' and Val '^^  are found in all 33 complete 
cONA sequences of adenylosuccinate synthetases, whereas Thr'^ ' and Thr^ '^ are present in 
32 of these sequences (serine was the alternative residue). In 24 of 32 sequences position 300 
is threonine, the alternative residue-type being valine. Overall identity amongst sequences 
with the adenylosuccinate synthetase family is approximately 46%. 
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Purity and secondary structure of mutant enzvmes^— The mutant and wild-type 
enzymes migrate comparably on phenyl sepharose and DEAE columns. All proteins were at 
least 95% pure on the basis of SDS-PAGE. The CD spectra of all enzymes were identical 
from 200—^260 imi (data not shown), indicating no major changes in secondary structure. 
Kinetics of mutant enzymes—The and for Thr'^ '->Ala and Thr'^ '->Ala 
are comparable to those of the wild-type enzyme (Table I). In contrast Thr'^ ^->Ala exhibits 
10- and 2-fold increases in and Km^, respectively, relative to wild-type enzyme, and 
Thr'^ ^-^Ala exhibits 30- and 80-fold increases, respectively, in the same parameters. 
Mutations of position 273 cause minor changes in Km^ and Km^, but increases 32-, 
40-, and 15-fold for the Ala '^^ , Asn '^^ , and Thr '^' mutant enzymes, respectively. The ikcat 
Val"^->Asn is 20-fold less than that of the wild-type enzyme, whereas ifccat Val"^-+Ala 
is triple that of the wild-type enzyme. The mutation of Thr^°® to alanine elevates by 
5-fold and by 30-fold. The and increase by approximately 2-fold or less 
due to the Thr '^^ '-^Val mutation, and kcu and increase 3-fold. The mutation of Thr^°' 
to alanine results in the complete loss of activity under conditions employed here (20 mM 
Hepes, pH 7.7,1 mM OTP, 500 nM IMP, 6 mM Mg2+ 25 mM ASP, 200 ^ig/ml of protein). 
Ala^®', Ala '^^ , Thr '^^ , Asn '^^  and wild-type AMPSases exhibit similar kinetic 
parameters when hydroxylamine replaces ASP (Table U). and vary 
over a 3-fold range, whereas kc» varies 5-fold amongst the enzymes of Table II. The Hill 
coefficient for Mg^*^, however, falls from 2 to unity when NH2OH replaces ASP (data not 
shown). 
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Inhibition of wild-type enzyme and position 273 mutant synthetase by succinate, 
fiimarate and maleate varies over a broad range of afRnities (Table lU). All kinetic 
mechanisms of inhibition are competitive with respect to ASP, and hence probably represent 
ligand interactions at a common locus within the active site. is at least 11-fold higher 
for wild-type and other position 273 mutants relative to the Thr^^^. Fimiarate is not an 
inhibitor of the wild-type synthetase, but exits fairly potent inhibition of the Asn^^^ mutant. 
On the other hand, maleate is 40-fold more potent as an inhibitor of the Thr^^^ mutant than 
the wild-type enzyme. 
DISCUSSION 
The residues studied here cluster in the vicim'ty of the ASP and IMP binding sites 
(14,20). The side-chain of Thr'^ ' hydrogen bonds with Asp' as Thr'^ ' hydrogen bonds 
with the 5'-phosphoryl group of IMP through its backbone amide group and its side chain. 
Interactions of threonines 128 and 129 putatively stabilize the IMP-bound conformation of 
the Loop 120—130, and enhance the afiim'ty of the active site for IMP. The side-chain of 
Thr^*'^  hydrogen bonds with backbone carbonyl 38 and the side-chain of His^^, but perlu^s 
more importantly, backbone amide 300 hydrogen bonds with the carboxyl group of 
hadacidin, a competitive inhibitor of ASP (Fig. 2). The carboxyl group of hadacidin is 
putatively the structural analogue of the p-carboxyl group of ASP. Thr^^* hydrogen bonds 
with the carboxyl group of hadacidin through its backbone anude and its side-chain, and also 
hydrogen bonds through its side-chain with Arg^"^. Arg^°^ in turn also hydrogen bonds with 
the carboxyl group of hadacidin. The interactions of Thr '^^ ' may be important in the 
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recognition of ASP and in the stabilization of an intramolecular hydrogen bond between its 
p-carboxyl group bond and its a-amino group (12,20). The P-carboxyl group of ASP 
putativeiy abstracts a proton from the a-amino group ASP in the second-step of the 
synthetase reaction (nucleophilic attack of the a-amino group of ASP on the atom C-6 of 6-
phosphoryl-IMP). The side-chain of Val^^^ makes nonbonded contacts with hadacidin. 
Although side-chains larger than the isopropyl group at position 273 could come into steric 
conflict with ASP, there are no obvious negative consequences in the substitution of side-
chains of smaller or similar in size to the isopropyl group. The backbone carbonyl of Val^^^ 
hydrogen bonds with the 2'-hydroxyl group of IMP, but this interaction may not be important 
as 2'-deoxy-IMP is a good substrate for the synthetase (29). 
Thr'^ *->AIa and Thr'^ '->Ala mutants exhibited 10- and 30-fold increases in 
respectively, while retaining wild-type levels of activity. Thus, Thr'^ ' and Thr'^ ' enhance the 
affim'ty of the active site for IMP. Presumably the hydrogen bond between Thr'^ ' and the 
conserved Asp"^ must stabilize the ligand bond conformation of Loop 120—130, enhancing 
the interactions between Thr'^ ^ and the S'-phosphoryl group of IMP. Evidently, only a small 
portion of the binding energy of the side-chain interactions of threonines 128 and 129 goes to 
the stabilization of the transition state {kcu falls only twofold due to these mutations). In this 
regard, threonines 128 and 129 are similar to Arg'^ ^. The side-chain of Arg'^ ^ firom a 
synunetry related monomer of the synthetase dimer hydrogen bonds with the S'-phosphoryl 
group of IMP. The mutation of Arg'^ ^ to leucine or lysine results in a 100-fold increase in 
and no change in kau (6,30). In contrast, the mutation of Asn '^, which also hydrogen 
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bonds with the S'-phosphoryl group of IMP, has no effect on but causes a 1000-fold 
decrease in (21). 
The 60-fold increase in Km relative to the wild-type enzyme for the Thr -^Ala 
mutant must come from an indirect mechanism, as Thr'^  and GTP are separated by more 
than 10 A. A 60-fold increase in was observed as well for Arg'*^->Lys and 
Arg'^ ^->Leu mutant enzymes (6,30). Correlated changes in and Km^ probably stem 
from the binding synergism between IMP and GTP, which may originate from the interaction 
of Asn '^ with the S'-phosphoryl group of IMP. In a crystal structure of an IMP-synthetase 
complex (Hou, Z., Fromm, H. J. and Honzatko, R. B., unpublished), Loop 40—52 adopts the 
conformation of the GDP-bound synthetase in the absence of guanine nucleotide. Evidently, 
IMP alone through its interaction with Asn^^, can stabilize the GDP-bound conformation of 
Loop 40—52. Correlated changes in and due to mutations at positions 129 and 
143, may stem fix)m a perturbation of the Asn '^-IMP interaction and a concomitant loss in the 
ability of IMP to drive conformational changes in Loop 40—52. 
The significant effects on and/or ^ due to mutations of threonines 300 and 
301 are in harmony with those observed in mutations of Arg^^^, and Arg^°^ and Arg^°^ to 
leucine (31). Crystallographic structures implicate Loop 398—^304 in the recognition of the 
P-carboxyl group of ASP (12,20). The 30-fold increase in for the Thr^°®-^Ala mutant 
is probably due to weakened hydrogen bonds between the P-carboxyl group of ASP and 
backbone amide 300, backbone amide 301, and the side-chain of Thr^ '^. The mutation of 
Thr^^ to alanine eliminates hydrogen bonds with backbone carbonyl 38 and His'^ , 
interactions which evidently help Loop 298—^304 in its ligand-bound conformation. Other, 
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more significant factors are at play here as well, however. The (^-branched side-chain at 
position 300 limits allowable main-chain torsion angles relative to the methyl group of 
alanine. The Thr^^^-^Val mutant enzyme, which retains conformational restraints on the 
backbone, but eliminates side-chain hydrogen bonds, causes only a 3-fold increase in 
and actually enhances by 300%. The modest effects of the Thr^^^-^Val mutation are 
consistent with the presence of valine at position 300, as an alternative to threonine, in 25% 
of known sequences for the synthetase. The 5-fold increase in due to the mutation of 
Thr^°® to alanine may reflect binding synergism between ASP and OTP. GTP/ASP binding 
synergism may stem in part from the coordination of each ligand to a common 
Furthermore, in a series of crystal structures Choe et al (14) demonstrate enhanced 
interactions between Arg^"^ (which putatively binds to the a-carboxyl group of ASP) and the 
a-phosphoryl group of the guanine nucleotide in the presence of hadacidin. 
As TW^^-^Ala mutant is inactive using ASP in assays, we are unable to determine 
whether the loss of activity is due to an effect on ^ or to a large increase in . If the 
mutation of Thr^°' to alanine eliminates critical hydrogen bonds with the P-carboxyl group of 
ASP, as inferred by crystallographic complexes (12,20), then the Thr^°'->Ala mutant enzyme 
and the wild-type enzyme should respond comparably to hydroxylamine as an alternative 
substrate. Indeed, kinetic parameters of the Thr'^ '-^Ala mutant are similar to those of the 
wild-type ens^me (Table QI). As ±e Km for hydroxylamine is lOOO-fold higher than the 
for the wild-type en:^e, the reaction involving hydroxylamine may be difiusion-
controlled. hicreased values for and Kx^ when using hydroxylamine as a substrate 
may then reflect the loss of binding synergism between ASP and the nucleotides 
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The Hill coefficient for when the synthetase is assayed in the presence of ASP 
and hydroxylamine is 2 and 1, respectively. The reduced Hill coefficient in synthetase-
mediated reactions which employ hydroxylamine reaffirms the correlated binding of ASP and 
a second in the kinetic mechanism of the synthetase (32). Evidently, only one Mg^*^ 
participates in the hydroxylamine reaction, whereas two are involved in the ASP reaction. 
Kang and Fromm suggest that a second Mg^^ binds to the carboxyl groups of ASP, in order to 
reduce the pK. of the a-amino group. An alternative model puts the second Mg^^ between 
the a-carboxyl group of ASP and the side chain of Asp'^  (3). Both models are consistent 
with the reduced Hill coefRcient observed in the presence of hydroxylamine. 
Although only non-bonded contacts are evident in crystal structures between Val^^^ 
and hadacidin, the mutation of Val^^^ to alanine causes a staggering 3S-fold increase in 
As the mutation puts a small side-chain in place of a larger one, increased steric 
interactions with the substrate are unlikely. Furthermore, the binding of ASP in its 
catalytically productive modes to the Ala mutant and wild-type enzymes must be nearly 
identical, as (which reflects ASP/GTP-binding synergism) and ^ are unchanged. 
Mutation to a larger side chain (Val^^^->Asn) causes a 40-fold increase in and a 20-
foid reduction in /tat, suggesting a perturbation in the mode of productive binding for ASP, 
due perhaps to the steric effects from a side chain with increased size. The isosteric mutation 
Val^"-»Thr, however, still causes a 15-fold increase in while ^ actually increases 
200%. 
Inhibition of position 273 mutants by dicarboxylic acids provides a measure of insight 
as to how Val^^^ functions in substrate recognition. Fumarate is a potent inhibitor of the 
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and Asn^^^ mutant enzymes, but has no effect on the wild-type en^mie, and similarly 
succinate and maleate become potent inhibitors of the Thr^^^ mutant enzyme. The active 
sites in position 273 mutants generally recognize a more diverse set of dicarboxylic acids 
than does the wild-type active site. This broadened recognition of dicarboxylic acids, may 
allow ASP to bind in different modes to the active sites of the position 273 mutants. The 
productive binding mode for ASP is retained in the Thr^^^ and Ala^^^ mutant enzymes but 
other, nonproductive binding modes for ASP may become important. Hence, the may 
increase for position 273 mutants enzymes because of competition between productive and 
nonproductive binding modes of ASP. 
Interestingly, Val^^^ lies between and makes non-bonded contacts with the side chains 
of arginines 303 and 305 (Fig. 3). The mutation of Val^^^ to alanine should expand the range 
of allowable conformations of these argininyl side chains, through the elunination of non-
bonded contacts. The mutation of Val^^^ to threonine may alter the conformations of 
arginines 303 and 305, as well. The side chain of Thr '^^  can hydrogen bond to Arg^®^, but the 
rotation about its bond necessary for this hydrogen bond would introduce bad steric 
contacts with Arg^®^. Hence, the Thr^^^ active site, through its perturbation on arginines 303 
and 305, could destabilize the productive recognition of ASP. Although position 273 
undergoes little conformational change between ligated and unligated conformational states 
of the synthetase, all residues in contact with the side chain of position 273 exhibit large 
conformational excursions in response to ligand association. Hence, small energy changes in 
the interaction of the side chain at position 273 with the surrounding protein could well lead 
to significant conformational change. 
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The kinetic properties of the above mutations are clearly consistent with the absolute 
sequence conservation of valine at position 273. hi fact, the selective pressures which retain 
position 273 as valine are now evident. In vivo concentrations of fiimarate, succinate and 
ASP in E. coli are approximately 0.4,0.4 and 2 mM (33,34). The mutations at position 273, 
presented here, are relatively conservative, yet each generates an enzyme which has a 
at least 10-fold higher than intracellular concentrations of ASP and vastly improved binding 
affinities for succinate and fumarate. Under physiological conditions, the position 273 
mutant enzymes are inactive. 
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Table 1 
Kinetic paramaters for wild-type and mutant adenylosuccinate synthetases* 
AMPSase *cat "•m K„IMP KM^SP *cat/Km®TP teal/Km'^ ®'' 
(s->) (uM) (HM) (mM) (s'VM"^ (s-^uM-l) (s"^mM"h 
wild-type 1.00 ±0.05 26.2 ±2.3 27.8 ± 1.3 0.23 ± 0.04 (3.8 ± 0.4) X 10-^ (3.58 ± 2.52) X 10-^ 4.4 ±0.8 
Thr"*-+Ala'' 0.46 ±0.03 53.9 ±6.1 307 ± 47 0.17 ±0.02 0.85 ±0.11 0.15 ±0.03 2.71 ±0.36 
Thr"'-^Ala' 0.42 ± 0.01 1700 ±60 894 ± 73 0.24 ±0.01 0.025 ±0.0001 0.047 ± 0.0004 1.75 ±0.08 
lW"®->Ala'' 0.64 ±0.04 165 ±13 18.7 ± 1.2 6.17 ±0.73 0.39 ±0.04 3.42 ±0.31 0.104 ±0.014 
Thi^°®->Val 3.34 ±0.17 55.8 ±5.8 32.8 ± 2.8 0.82 ± 0.02 0.60 ±0.07 10.1 ± 1.0 4.07 ±0.23 
Thr'®'->Ala ND' ND' ND' ND' ND* ND' ND' 
Val"'->Ala' 1.00 ±0.1 31.1 ±3.0 16.5 ± 1.8 7.36 ± 1.4 3.2 ± 0.5 6.1 ±0.9 0.14 ±0.03 
Val"'->Asn' O.OS ± 0.00 20.8 ±1.9 23.6 ±2.1 9.2 ±2.1 0.24 ±0.02 0.21 ± 0.02 0.0055 ± 0.001 
Val"^-^Thr' 1.99 ±0.02 45.1 ±6.5 43.1 ± 3.7 3.4 ±0.2 4.4 ±0.01 4.6 ±0.6 0.61 ±0.07 
*Eiuyine assay solution contained 20 mM Hepes, pH 7.7, S mM MgCl2, and fixed concentrations for two of die three substrates, as appropriate, in die 
determination of for the remaining substrate. The fixed concentrations of GTP, IMP and aspartate were 0.30,0.SO and S.O mM, respectively, for 
wild-type AMPSase, and unless otherwise specified for the mutant AMPSases. 
0.25 mM IMP and 0.45 mM GTP used 
*6 mM IMP and 0.60 mM GTP used 
'25inM ASP used 
*ND - Not Detectable/Not Determined 
*25 mM MgClj used when varying ASP, 25 mM aspartate used 
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Table n 
Kinetic parameters of wild-type and mutant AMPSases with NH2OH* 
AMPSase kaa WKW - fcr CTP • e IMP 
i s ' )  (mM) (^lM) (mM) 
wild-type 0.50 ±0.09 230 ±80 185 ±22 66±7 
Thr^°'->Ala 0.24 ±0.04 91 ±3 56.8 ± 6.8 316 ±86 
Val '^^ ->Ala 0.21 ±0.02 255 ±60 142 ±40 140 ±20 
Val^^-^Asn 0.29 ±0.08 109 ±65 180 ±30 113±7 
Val '^'^ ->Thr 0.080 ±0.002 136 ±34 74±8 77±6 
'Peifonned as described in "Experimental Procedures". 
Table 01 
Inhibition constants for wild-type and mutant AMPSases' 
AMPSase K.si;c jr.FUM f^ MAE 
(MM) (UM) (mM) 
wild-type 890 ± 50 Nl" 3.1 ±0.8 
Val"'-»Ala Nl" 176 ±40 l.0±0.2 
Val '^^ ->Asn Nl" 42 ±12 0.21 ±0.08 
Val2"-+Thr 75 ±11 640 ±80 0.078 ±0.005 
'Perfonned as described in "Experimental Procedures" 
'^ on-Inhibitoiy (to 10 mM) 
Figure 1 - UV absorbance difference spectra for reactions catalyzed by AMPSases using 
GTP, IMP Mg^"^ and (A) aspartate as the substrate, (B) NH2OH as the substrate, or (C) 

















Figure 2 - Computer modeling of the IMP and hadacidin binding sites. The hydrogen bonds 




[H  ^ ^AtgdOS Arg304' ^^Afg305 
Arg303 Arg303 
Figure 3 - Computer modeling of non-boning contacts between Val '^^ , Arg^®^, and Arg^®' 
89 
CHAPTER V. GENERAL CONCLUSION 
Adenylosuccinate synthetase has been studied for over 40 years, starting with its 
initial discovery and elucidation of the catalyzed reaction, its placement in the purine 
nucleotide pathway, and tissue specific role in higher organisms. Since cloning of the gene, 
the details of the mechanics of how this enzyme works as a biological catalyst have been the 
focus of enzymatic studies. The importance of this enzyme lies in its place in the metabolism 
of purine nucleotides. It has been shown to be a target for natural antibiotics (1), 
herbicides(2), and for treatment of certain leukemias(3). In studies presented in this 
dissertation, the roles of certain residues in the fimction of the enzyme were examined, and 
the building blocks for the future exploration of this engine. Presented in this dissertation 
are the discussion of the state of association of the active form of the en^mie, and the 
difficulties which arise when using only directed mutations or crystal structures to assign 
roles to residues and their side chains. 
First, the actual state of association of the enzyme was investigated. Monomeric and 
dimeric states of AMPSase had previously been reported in the literature (4,5), and all crystal 
structures of the enzyme are dimeric. Two residues which are located at the interface and 
implicated in dimer interactions from the crystal structures are Asp '^ and Arg'^ ^. Arg'^ ^ is a 
unique residue, as the side chain is involved in IMP binding at the active site of the 
symmetry-related monomer (Fig. lb. Chapter II). Asp '^ in the crystal structures forms 
hydrogen bonds with Arg'^ ^ and Lys'^ °, two residues which had previously been implicated 
by modification studies to be important in the activity of the enzyme (6,7). The mutations 
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Asp"'->Ala, Arg'^ ^-»Leu and Arg'*^->Lys residues were made to disrupt the interface, so 
the importance of dimer interactions to enzyme activity could be determined. 
When studied by MALDI, the wild-type enzyme showed the presence of both 
monomers and dimers. Sedimentation equilibrium analytical also showed the presence of 
both monomer and dimer states when performed in the absence of active site ligands. In the 
presence of ligands, the enzyme was exclusively a dimer, the wild-type AMPSase Kd drops 
from 11.2 )iM to 1.03 x 10'^ ' (Table IV, Chapter II). In contrast, all of the mutant 
enzymes show only slightly lower Kd values when in the presence of ligands (Table FV, 
Chapter II), indicating the mutations do indeed affect the state of association. The Acat values 
of the three mutants are comparable to that of the wild-type enzyme, however they show 
large increases in (60- to 100-fold). 
The enzyme exists as a monomer in the micromolar concentrations, which is the same 
range as the intracellular concentration of the enzyme. Binding of substrates shifts the 
monomer-dimer equilibrium to the dimer form of the enzyme. As this enzyme lies at the 
branch point from IMP in the de novo biosynthetic pathway, this ligand-induced dimerization 
may be an important regulatory mechanism in the control of the AMPSase reaction. 
Chapter III investigates the roles side chains of amino acid residues 21,38,42 and 
419 play in recognition and binding of the nucleotide IMP. Upon examination of the 
mutants, a number of unexpected results were obtained. In the crystal structure, Asp '^ and 
Arg '^^  go from disordered conformations to form a salt-link in the ligated enzyme. In the 
ligated structure, Thr^^ forms a salt-link with the guanine base, and the side chain of Asn '^ 
appears to clearly form a hydrogen bond with the S'-phosphoryl of IMP, and thus should be 
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important to the binding of IMP. Asp '^ and Arg '^^  mutations are not located within any 
active site, yet mutation of either creates a drop in the of the mutants. 
With the rapid equilibrium random mechanism, represents the breakdown of the 
quaternary complex of enzyme-substrate to enzyme-products, and is thus sensitive to changes 
in the transition state. Transition state stabilization yields an mcrease in while 
destabilization yields a decrease in kat. The mutations discussed are not located in the active 
site, but in a substrate binding site, they must effect the active site though an indirect 
mechanism. This could be though either destabilization of the 40's loop, or through 
perturbations in the P-Ioop. Thr'*^ therefore also plays an indirect role, most likely though 
this 40's loop, as mutation causes approximately 10-fold increases in Km^. 
Mutation of Asn '^ to glutamine and aspartic acid shows that this residue plays no 
role in IMP binding (no influence on However, this residue is located in a short 
element which immediately precedes a loop (40's loop) which undergoes a 9 A movement 
upon ligand binding. Bindmg of the substrate moves the 40's loop from an "open" position 
to a "closed" position (Fig. 2, Chapter III). As Asn '^ plays no part in the binding of the 
substrate, the binding energy of this residue goes directly into moving the 'hinge' of a loop 
on the enzyme. These results help to remind us that a direct interaction seen in a crystal 
structure does not necessarily mean that it is required for the binding of the substrate, or that 
this is truly the function of that interaction. 
Chapter IV further looks at the roles of direct and indirect interactions seen in the 
crystal structure on the binding of substrates. The study focused on a group of conserved P-
branched side chains located near the S'phosphate of IMP and carboxyl groups of L-
aspaitate. Residues Thr'^ ^ and Thr^ '^ have direct interactions with IMP and L-aspartate, 
92 
respectively. Thr'^ ' and have indirect interactions with these same substrates (Fig. 2, 
Chapter IV). Thr'^ ' interacts with substrates through contact with Asp"^ in Loop 120 -130, 
and the backbone carboxyl interacts with ASP in the case of Thr^°®. Additionally, Val '^^  has 
no bonded contacts with ASP, though there are backbone interactions with Arg^°^ and Arg^^^ 
(Fig.3, Chapter IV), yet is conserved across all known AMPSases. 
The effect on the steady-state kinetics by the mutant em^es reflects the stabilization 
of the bound complexes by indirect hydrogen bonding as seen by the Thr'^ ' and Thr^"® 
mutants. Removal of these interactions by mutation to alanine causes an increase in the 
and while causing only minor perturbations in the Acu (Table I, Chapter FV). 
The effects of conformational restrains on the main chain of enzyme for L-aspartate 
recognition are seen from mutation of Thr^°® to valine. The Thr^°°->Val mutant enzyme 
retains conformational restraints on the backbone, but eliminates side-chain hydrogen bonds. 
This results in only a 3-fold increase in and actually enhances k^t by 300% (Table I, 
Chapter IV). As there is a naturally occurring valine in 25% of the known AMPSase 
sequences, this supports selection of either a theronine or valine in this position. 
Direct interaction effects between substrates and side chains are seen for the residues 
129 and 301. Thr'^ ' forms a direct contact with the S'-phosphoryl of IMP, while crystal 
structures show Thr^°' hydrogen bonds with the carboxyl group of hadacidin through both its 
backbone amide and its side-chain, and additionally hydrogen bonds to Arg^^^ through its 
side-chain. Mutation of Thr'^ ' to alanine only effects the (Table I, Chapter IV). So 
unlike the mutations seen in Chapter III, only a small portion of the binding energy of the 
side-chain interactions, be they direct or indirect, for threonines 128 and 129 goes to the 
stabilization of the transition state falls only twofold due to these mutations). The direct 
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interaction of Thr^"' is essential for ASP binding, as when this interaction is removed, 
binding of ASP is removed. However the enzyme remains competent, as reaction occurs 
with hydroxylamine (Table II, Chapter IV). 
The effect of a side-chain that from the crystal structure would not seem important is 
striking. What is the selective pressure to maintain a valine at this position, as is found in all 
known AMPSases? Inhibition of position 273 mutants by dicarboxylic acids provides a 
measure of insight as to how Val^^^ functions in substrate recognition. The mutants at this 
position show that there is an increase in the permissiveness of the biding site, seen in the 
drop of Ki for dicarboxylic acids. The intracellular concentrations of succinate and fimiarate 
are sufficiently large enough to cause the Val^^^ mutant enzymes to be inactive under 
physiological conditions (8,9). This helps explain why there is a consistent valine at this 
position. The role of the non-bonding contacts is to prevent binding of nonproductive 
conformations of substrates, as seen by inhibition studies. The productive binding mode for 
ASP is retained in the Thr '^^  and Ala"^ mutant engines but other, nonproductive binding 
modes for ASP may become important. Therefore, for position 273 mutant enzymes 
may increase due to competition between productive and nonproductive binding modes of 
ASP. 
The studies which were undertaken to investigate the roles of specific interactions in 
the substrate recognition of AMPSase yielded both expected and unexpected results, leading 
to insights for the mechanism of the enzyme. The results show the dangers of utilizing only a 
crystal structure or only a kinetic study to assign a role to a specific side chain or interaction, 
and these tools need to be utilized in conjimction to determine the function of a specific 
interaction or role of a side chain. Additionally, they highlight the fact that the interactions 
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deemed insignificant can play a larger role in the recognition of substrates, and clues as to 
their importance should not be overlooked. 
Future direction in the study of E. coli AMPSase is to answer the question of the 
second magnesium which has been raised. Kang showed there are two found in the 
reaction(10), yet the presence of this second Mg^^ has yet to be seen in the crystal structure, 
while Honzatko proposed an alternative model where the second Mg^*^ is between the a-
carboxyl and ASP and Asp'^  side chain. Additionally, a study on the differences between the 
isozymes which exist to see what gives rise to the differences needs to be done. To this end, 
a recombinant muscle isozyme has been produced. The enzyme has been characterized using 
both kinetic and biophysical techniques. Now that a recombinant form of the isozyme exists, 
the ability to examine what the structural basis for the difference between muscle/non-muscle 
and £ coli enzymes. 
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